Top

Sai-Ching J Yeung, B.S., R.Ph., M.S., Ph.D., M.D., F.A.C.P.

Department of Emergency Medicine, Division of Internal Medicine

About Dr. Sai-Ching J Yeung

Dr. Yeung is a physician-scientist with a multi-disciplinary background in pharmacy, internal medicine, endocrinology/metabolism, and cancer research. His research ranged from basic science, translational research, to clinical research. He has extensive (27 years) clinical experience in oncologic emergencies and has published extensively in this realm. A couple of his focus areas in oncologic emergencies are pain, sepsis, and neutropenic fever. He has conducted many clinical studies related to oncologic emergencies, including a randomized controlled interventional clinical trial to study an opioid formulation for cancer patients with pain in the emergency setting. Dr. Yeung has produced clinical predictive tools to stratify the short-term mortality risk of cancer patients in the Emergency Department with suspected systemic infection. His recent research has focused on the impact of immune-mediated adverse effects (irAEs) caused by immune checkpoint inhibitors in cancer patients presenting to the Emergency Department. He is active in the Comprehensive Oncologic Emergency Research Network (COncERN) and has coauthored multiple papers with this group. He has produced clinical predictive tools to stratify the short-term mortality risk of cancer patients in the Emergency Department with suspected systemic infection. Dr. Yeung joined MD Anderson in 1997 and has completed numerous publications. A complete list of Dr. Yeung's published work can be found in: http://www.ncbi.nlm.nih.gov/sites/myncbi/1tMh4ZwC8XuAa/bibliograpahy/47436494/public/?sort=date&direction=ascending

Primary Appointment

Internist and Professor of Medicine, Department of Emergency Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Director, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

Current: My recent research has been funded by NCI through a multi-PI RO1 grant to study the prediction of appropriate emergency department (ED) disposition for cancer patients treated with immune-checkpoint inhibitors. Recently, there has been a big leap in advances in artificial intelligence (AI) and the capability in natural language processing (NLP) and large language models (LLM). I am a co-investigator on an internal institutional research grant to use the AI method to predict the proper disposition of ED patients with cancer.

Research Accomplishments: We were funded by the US Department of Defense (DOD) and Susan G. Komen Foundation for breast cancer research. Both grants focused on the impact of diabetes and obesity on cancer. My contributions to this field of research have been well-recognized and I have been an invited lecturer on the topic of diabetes and obesity on cancer at a number of national and international forums, including the 71^st Annual Convention of the American College of Osteopathic Internists (ACOI), the American Association of Clinical Endocrinologists (AACE) Consensus Conference on Diabetes and Cancer, a European symposium at DOCRATES Cancer Center, Helsinki, Finland, a seminar of the Tainan Oncologic Society, Tainan, Republic of China, and an Institutional Seminar at the Key Laboratory of Molecular and Developmental Biology, Chinese Academy of Sciences, and Beijing, the People’s Republic of China. I am also a member of the AACE Task Force for the Diabetes, Obesity, Insulin Resistance, Anti-Diabetic Agents, and Cancer Conference.

This line of research on the impact of diabetes and cancer began when I was Principal Investigator for a multidisciplinary research grant as well as collaborating on a sub-project with Dr. Donhui Li, GI Medical Oncology, on the association of metformin with pancreatic cancer (which resulted in two published papers). After Dr. Weiser’s untimely death, I took over her clinical trial investigating the impact of an intensive insulin regimen on the clinical outcome of hyperglycemic acute lymphoblastic leukemia patients undergoing hyper-CVAD chemotherapy.The trial was terminated early because intensive insulin was associated with adverse outcomes in ALL. Secondary analyses suggested that exogenous insulin was associated with a poor prognosis, while metformin and thiazolidinediones were associated with good prognoses. These results were published in Clinical Lymphoma Myeloma & Leukemia in 2012. Working with my ex-postdoctoral fellow (Dr. Jingxuan Pan, Chairman of Pathophysiology, Sun Yat-sen University School of Medicine, Guangzhou, China), in vitro laboratory studies also demonstrated that insulin induced chemo resistance while metformin and thiazolidinedione increased chemo sensitivity in ALL cells, and these results were published in Cell Cycle in 2012. In collaboration with Dr. Shi-Ming Tu (Genitourinary Medical Oncology), I directed my mentee Dr. Xuexin He (Assistant Professor, Zhejian Medical University, Hangzhou, China) to perform a retrospective clinical study that demonstrated the association of metformin and thiazolidinedione with improved overall survival of prostate cancer, and these results were published in Annals of Oncology in 2011. I guided Dr. He in another study of antidiabetic medications on HER2-positive breast cancer in collaboration with Dr. Francisco Esteva (Breast Medical Oncology) and published another article in Annals of Oncology in 2012. Dr. He returned to MDACC as a Visiting Scientist again in 2018, and we analyzed breast cancer patient data and published several more papers about factors that influenced breast cancer patient survival. In collaboration with Dr. Mong-Hong Lee (Molecular & Cellular Oncology), our project to investigate the impact of diabetes and anti-diabetic treatments on HER2-positive breast cancer using a mouse model was funded by the DOD. We successfully bred a model of breast cancer and type 2 diabetes by crossbreeding lepr ^db/+ with transgenic MMTV-neu mice and showed that diabetes accelerated the formation of breast cancer and shortened cancer-specific survival. The anti-diabetic medications metformin and rosiglitazone improved the survival of diabetic mice with breast cancer. We are in the process of analyzing this data and pursuing publication. I am the lead of a multidisciplinary team, which includes Dr. Mong-Hong Lee, Dr. Wallace McKeehan (Texas A&M Institute of Biotechnologies), and Dr. Francisco Esteva, to investigate the impact of obesity and anti-obesity treatments on estrogen receptor-positive breast cancer using mouse models and to conduct a randomized clinical trial to investigate the combination of metformin, everolimus, and exemestane in the treatment of metastatic ER-positive breast cancer among obese and overweight patients. That project was funded by a Promise Grant ($7.2 million dollars) from the Susan G. Komen Breast Cancer Research Foundation, of which I was the Principal Investigator. In collaboration with Dr. Cynthia Perez (Epidemiology, the University of Puerto Rico School of Medicine, San Juan), I mentored Dr. Ana Ortiz (Epidemiology, the University of Puerto Rico School of Medicine, San Juan) in an active pilot project funded under the U54 grant for University of Puerto Rico and MD Anderson to investigate the association of metabolic syndrome with breast cancer in Puerto Rico. I have managed and helped coordinate all these different research projects. Dr. Vincente Valero and Dr. Clinton Yam completed the Phase II clinical trial of exemestane, everolimus, and metformin for obese or overweight postmenopausal ER+ breast cancer patients and published the results.

Early in my research career, I worked in the realm of experimental therapeutics, examining farnesyltransferase inhibitors for the treatment of anaplastic thyroid cancer. This line of investigation resulted in 14 peer-reviewed publications for which I was the corresponding author. Continuing in the realm of experimental therapeutics, we investigated hypoxia-induced Pim1 protein elevations as a target for combating hypoxia-induced chemo resistance. We have published two peer-reviewed papers on this topic and received funding by Astra-Zeneca to evaluate several Pim kinase inhibitors against pancreatic cancer both in vitro and in vivo. Investigation of a specific aurora B kinase inhibitor, AZD1152, has resulted in three peer-reviewed publications. One of these papers was published in the Proceedings of the National Academy of Sciences, USA (PNAS).

My close collaborator, Dr. Mong-Hong Lee, focuses on basic science research on the subunits of COP9 signalosome (CSN6) and the tumor suppressor 14-3-3sigma. I have contributed significantly to his research, and we have coauthored 44 papers together so far; notable publications were published in prestigious journals such as Journal of Clinical Investigation, Cancer Research, Nature Communications, Cancer Cell, etc.

While I was collaborating with Dr. Lee, I frequently visited the Department of Molecular Oncology and got to know Dr. Hao Zhang, who later became faculty in Shantou University School of Medicine in China. I formed a successful long-term collaboration with Dr. Zhang, and we have published over 15 papers, with more to come.

Future Directions: I was the Principal Investigator for a lab-based clinical protocol to examine serum samples from Emergency Center patients with sepsis to identify microRNA and cytokine patterns predictive of sepsis and the prognosis of septic patients. MicroRNA profiling was performed by Dr. George Calin’s laboratory (Experimental Therapeutics). We have completed and published this study in the Journal of Clinical Investigation and are in the process of applying for NIH funding to further study anti-microRNA as a sepsis therapy.

Ongoing research data in oncologic emergency medicine is obtained from sources such as registries or surveys, which lack granularity, functional status, symptom inventories, and other variables critical to understanding Emergency Department (ED) visits by cancer patients. To address this knowledge deficiency, the National Cancer Institute (NCI) has formalized a Comprehensive Oncologic Emergencies Research Network (CONCERN), which is a multicenter research consortium including representatives from both oncology and emergency medicine. As an active collaborator with several ED investigators, we have collectively analyzed and published about a multi-center prospective cohort of cancer patients presenting to US emergency departments. I have co-authored more than 6 publications with the CONCERN group.

Broadly speaking, my future direction of research will involve oncologic emergencies (focusing on sepsis) and clinical management of oncologic emergencies (focusing on immune-related adverse events) with application of AI and LLM methodologies.

Clinical Interests

Patient care continues to remain a priority in my career. My clinical activity is in the Emergency Center. I used to provide coverage for 40-plus hours per week, similar to other faculty members in the Emergency Medicine, which at the time was a section of the Department of General Internal Medicine until 2010. Historically, I generated over $800,000 in billing. Since the creation of the Department of Emergency Medicine, my clinical work load has been reduced to 30 hours per week to allow me to spend more time on research and scholarly activities. For fiscal years 2016, 2017 and 2018, I generated gross revenues of $549,484, $549,174, and $590,618 respectively, which are equivalent to 2,525, 2,522, and 2,728 RVUs (3-year averages: $563,092 in gross patient revenues and 2,592 RVU). I have worked in the Emergency Center since 1997 and am the longest-serving faculty member (27 years) with the most experience in oncologic emergencies, having provided care to over 20,000 cancer patient encounters. Oncologic emergency medicine is my principal area of clinical expertise. This unique experience has enabled me to develop scholarly insights focused on this newly recognized area of cancer patient care.

I organized and recruited contributing authors, as well as co-edited the most comprehensive text on oncologic emergencies, Oncologic Emergencies, published by B. C. Decker in 2002. This Oncologic Emergencies book was endorsed by the American Cancer Society. I was subsequently invited by Dr. Robert Bast to contribute chapters on oncologic emergencies to the 6^th, 7^th, 8^th, and 9^th (the most current) editions of Cancer Medicine—a comprehensive oncology textbook. Recognizing the importance of the emerging field of oncologic emergencies, I served as co-chair of the organizing committee for the inaugural MD Anderson Oncologic Emergencies Conference in 2003, where I lectured on endocrine and metabolic emergencies. In conjunction with text published in 2002, more recently, I also edited and published chapters in two additional books: Manzullo E, Yeung SC, Gonzalez CE, and Escalante C. (editors). Oncologic Emergencies. Springer-Verlag: New York, 2016. Todd KH, Thomas CR (editors). Yeung SJ (Section Editor). Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing: 2016. I am frequently invited to speak on the topic of oncologic emergencies at numerous local, national, and international forums. Thus, I have established myself as an oncologic emergency medicine expert and will continue to contribute to this emerging and important area of cancer patient care. For the upcoming third edition of Oncologic Emergency Medicine: Principles and Practice, I have signed the contract to be a co-editor together with Dr. Christopher Coyne and Dr. Patricia Brock.

In the realm of endocrinology, I am the primary author of the online chapter for Graves’ disease in eMedicine (http://emedicine.medscape.com/article/120619-overview), which continues to be a highly accessed resource for online users. I co-authored The Physicians' Information and Education Resource (P.I.E.R.) online module for perioperative care of hypothyroid patients on the American College of Physicians website. I have a clinical interest in endocrine complications of cancer therapy and have written a review article on this subject in Endocrine Reviews (Impact Factor: 19.761). I co-authored the Diagnosis and Management of Lung Cancer, 3^rd Edition—practice guidelines by the American College of Chest Physicians (ACCP) as the primary author for the section addressing paraneoplastic syndromes. The ACCP practice guidelines are in press for the journal Chest. It was an honor to serve on the expert author panel of such an influential national medical organization.

As advances in cancer therapy lead to improved patient survival, internal medicine issues of cancer patients are increasingly important. Thus, I led the effort and co-edited a textbook, Medical Care of Cancer Patients, published by B. C. Decker in 2010 with Drs. Robert Gagel and Carmen Escalante. This unique book covers many issues in the care of cancer patients that are not covered in oncology textbooks.

Education & Training

Degree-Granting Education

1991	St. Louis University, School of Medicine, St. Louis, Missouri, US, Medicine, Doctor of Medicine
1988	University of Houston, College of Natural Sciences and Mathematics, Houston, Texas, US, Biology, Doctor of Philosophy
1985	University of Houston, College of Natural Sciences and Mathematics, Houston, Texas, US, Biology, Master of Science
1983	University of Houston, College of Pharmacy, Houston, Texas, US, Pharmacy, Bachelor of Science

Postgraduate Training

1994-1997	Clinical Fellowship, Endocrinology, Baylor College of Medicine and MD Anderson Cancer Center Joint Program, Houston, Texas
1992-1994	Clinical Residency, Internal Medicine, Baylor College of Medicine, Houston, Texas
1991-1992	Clinical Internship, St. Luke’s Episcopal Hospital Program, Baylor College of Medicine, Houston, Texas

Licenses & Certifications

1997	American Board of Internal Medicine, Subspecialty Board in Endocrinology and Metabolism
1994	American Board of Internal Medicine
1992	Licensed Physician of Texas
1983	Registered Pharmacist

Experience & Service

Faculty Academic Appointments

Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019

Associate Professor, Department of Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, 2011 - 2013

Associate Professor, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013

Associate Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2010

Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2013

Assistant Professor, The University of Texas Medical School, Houston, TX, 2002 - 2007

Assistant Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1997 - 2006

Clinical Instructor, Department of Medicine, Baylor College of Medicine, Houston, TX, 1994 - 1997

Administrative Appointments/Responsibilities

Research Director, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present

Deputy Chief, Section of Emergency Care, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2010

Other Professional Positions

Member, Breast Cancer Research Program, BCRP TRN-CBY-B panel, DOD, Houston, TX, 2010

NIH Member, Cancer Molecular Pathobiology SRO, ONC1-Basic Translational IRG,, Houston, TX, 2009

Member, Biomedical & National Medical Research Councils of Singapore, Singapore, 2003 - 2005

Staff Pharmacist, St. Louis University Hospital, St. Louis, MO, 1989 - 1991

Staff Pharmacist, Sun Belt Regional Medical Center, Houston, TX, 1984 - 1987

Teaching Assistant in Animal Physiology, University of Houston, Houston, TX, 1983 - 1983

Research Assistant in Neurobiology, University of Houston, Houston, TX, 1980 - 1983

Physics Tutor, University of Houston, Houston, TX, 1979 - 1980

Extramural Institutional Committee Activities

Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2013 - Present

Member, Institutional Research Grant Review Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

Member, PBHSRC- Psychosocial, Behavioral, and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2013

Member, Medical Practice Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2012

Member, Institutional Biosafety Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2008

Member, Department of Internal Medicine Research Committee, Biomarker Subcommittee, The University of Texas MD Anderson Cancer Center, 2006 - 2010

Member, Institutional Research Grant Review Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2008

Member, Clinical Research Council, The University of Texas MD Anderson Cancer Center, 2005 - 2007

Member, Institutional Research Grant Review Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2005

Editorial Activities

Associate Editor for CardioOncology section, Frontiers in cardiovascular medicine, 2023 - Present

Editorial Board Member, Cancers, 2022 - Present

Associate Editor, Annals of medicine, 2021 - Present

Editorial Board Member, Emergency Cancer Care, 2021 - Present

Editorial Board Member, PloS one, 2018 - Present

Endocrinology Specialty- Editor in Chief, WebmedCentral Plus, 2013 - 2020

Member of Editorial Review Board, Cancer Hallmark, 2012 - 2020

Editorial Consultant, ACP Medicine, 2005 - 2015

Honors & Awards

2023	Certificate for outstanding contribution in Open Science, Wiley Open Science Excellent Author Program
2022 - 2027	Ashbel Smith Professor, The University of Texas System
2021	Albert Nelson Marquis Lifetime Achievement Award, Albert Nelson Marquis
2019	Division of Internal Medicine - Clinical Research Distinguished Paper Award, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center
2014	US Faculty Scholar 2014, Vietnam Education Foundation
2013	US Faculty Scholar 2013, Vietnam Education Foundation
2006	Continental WHO's WHO (Lifetime Member), WHO's WHO of America
2002	Fellow of American College of Physicians, American Society of Internal Medicine
2001	Strathmore’s WHO’s WHO (Lifetime Member)
1991	Wendell Griffith Award in Biochemistry, St. Louis University, School of Medicine
1986	Research Excellence Award, University of Houston, Biology Department
1982	Phi Kappa Phi Honor Society (Lifetime Member)

Professional Memberships

Society of Academic Emergency Medicine

2024 - Present

International Association for the Study of Lung Cancer

2022 - Present

American Society of Clinical Oncology

2019 - Present

Chinese American Doctors' Association of Houston

2013 - Present

American College of Physicians

2002 - Present

American Association for Cancer Research

2001 - Present

Endocrine Society

1999 - 2013

American Thyroid Association

1998 - 2013

American Medical Association

1997 - Present

Harris County Medical Society

1997 - Present

Texas Medical Association

1997 - Present

Selected Presentations & Talks

Local Presentations

2014. Biomarkers in Sepsis. Conference. Baylor College of Medicine. Houston, TX, US.
2014. The Impact of Diabetes and Anti-diabetic Medications on Cancer. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
2013. Oncologic Emergency: The Perspectives from a Comprehensive Cancer Center. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2013. Oncologic Emergency: The Perspectives from a Comprehensive Cancer Center. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2011. The Impact of Anti-diabetic Treatments on Pancreatic Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2011. The impact of obesity and diabetes on the outcome of malignancy. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2011. The Impact of Obesity and Diabetes on Malignant Diseases. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2011. The impact of thiazolidinediones on the survival of prostate cancer: potential involvement of bone metastasis. Conference. Houston Area Bone Club. Houston, TX, US.
2009. Obesity and breast cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2009. The impact of type II diabetes mellitus and obesity on cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2008. The Impact of Diabetes Mellitus Type 2 and its Treatment on Cancer: Cellular Mechanisms. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2007. The Impact of Diabetes and Diabetes Treatment on Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2006. Diabetes and cancer: Background and preliminary work in a multidisciplinary research program. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2003. Oncologic Emergencies. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2003. Two distinct pathways of cytochrome c release in drug-induced apoptosis: investigation by the combination of paclitaxel and manumycin. Conference. Baylor College of Medicine. Houston, TX, US.
2003. Analysis of nuclear DNA Content in the diagnostic work-up of follicular thyroid nodules: clinical value and cost-effectiveness. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2002. Analysis of nuclear DNA Content in the diagnostic work-up of follicular thyroid nodules: clinical value and cost-effectiveness. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2000. The Involvement of caspase activation and cytochrome c release in anaplastic thyroid cancer cell apoptosis enhanced by the combination of paclitaxel and manumycin. Conference. Baylor College of Medicine. Houston, TX, US.
2000. The enhancement of apoptosis in anaplastic thyroid cancer cells by the combination of paclitaxel and a farnesyltransferase inhibitor (manumycin). Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
1998. The Endocrine effects of antineoplastic therapy. Conference. Baylor College of Medicine. Houston, TX, US.

National Presentations

2013. Oncologic Emergency: The Perspective from a Comprehensive Cancer Center. Conference. 2nd Medical Issues in Cancer Patients & Survivors Conference. Houston, TX, US.
2012. Diabetes Management and Cancer Risk: Thiazolidinediones and Cancer. Invited. Consensus Conference on Diabetes and Cancer. New York, NY, US.
2011. The impact of obesity and type II diabetes mellitus cancer. Invited. 71st Annual Convention and Scientific Sessions. San Antonio, TX, US.
2009. Endocrine Issues in Cancer Survivors. Invited. Medical Issues in Cancer Survivors. Houston, TX, US.
2007. Type II Diabetes and Cancer: Cellular Mechanisms. Invited. Diabetes Conference. Houston, TX, US.
2006. Metabolic Emergencies in Cancer Patients. Invited. Oncologic Emergencies Conference. Houston, TX, US.
2003. Endocrine and Metabolic Emergencies in Cancer Patients. Invited. Oncologic Emergencies Conference. Houston, TX, US.

International Presentations

2018. Clinical applications of cancer genomics in therapeutic optimization and development. Conference. Inaugural Ceremony of Vietnam. Nha Trang, VN.
2018. Oncologic Emergencies: The perspective at a comprehensive cancer center. Conference. International Breast Cancer Symposium 2018. Hue City, VN.
2017. Oncologic emergencies of patients with advanced cancer. Conference. Qilu Pharmaceutical Co Ltd. Haikou, CN.
2017. Oncologic Emergencies: A perspective at a comprehensive cancer center. Conference. Oncologic Emergency Conference. Guangzhou, CN.
2017. Oncologic Emergencies: The perspective at a comprehensive cancer center. Conference. Oncologic Emergency Conference. Chengdu, CN.
2017. Oncologic Emegencies: The perspective at a comprehensive cancer center. Conference. Oncologic Emergency Conference. Yunnan, CN.
2016. Small Cell Lung Cancer: Endocrine Paraneoplastic Complications. Invited. Neuroendocrine Cancer Section of Yunnan Province Lung Cancer Association. Kunming, CN.
2016. Oncologic Emergencies: The perspective at a comprehensive cancer center. Invited. Breast Cancer and Oncologic Emergency Conference. Hangzhou, CN.
2016. Oncologic Emergencies: The perspective at a comprehensive cancer center. Invited. Breast Cancer and Oncologic Emergency Conference. Jinan, CN.
2016. Oncologic Emergencies: The perspective at a comprehensive cancer center. Invited. Breast Cancer and Oncologic Emergency Conference. Shanghai, CN.
2015. Biomarkers in Oncologic Emergencies: Prognostic value of troponin I in cancer patients with septic shock. Invited. The Eighth Mediterranean Emergency Medicine Congress organized by American Academy of Emergency Medicine. Rome, IT.
2013. Oncologic Emergency: The Perspective from a Comprehensive Cancer Center. Invited. Shanwei City Cancer Symposium. Shanwei, CN.
2012. The impact of obesity and type 2 diabetes mellitus on cancer. Invited. Nuclear endocrinology and emergency oncology symposium. Helsinki, FI.
2012. Endocrine paraneoplastic syndromes of lung cancer patients. Invited. Nuclear endocrinology and emergency oncology symposium. Helsinki, FI.
2012. Oncologic emergency: the perspectives from a comprehensive cancer center. Invited. Nuclear endocrinology and emergency oncology symposium. Helsinki, FI.
2008. Antineoplastic effects of an aurora B kinase inhibitor against breast cancer. Invited. EHRLICH II - World Conference on Magic Bullets. Nürnberg, DE.
2008. The impact of type II diabetes mellitus and its treatments on cancer: cellular mechanisms. Invited. Tainan Oncologic Society. Tainan, CN.

Formal Peers

2015. The impact of obesity and diabetes on cancers. Invited. Iowa City, IA, US.
2014. The impact of diabetes and antidiabetic medications on cancers. Invited. Shantou, Guangdong, CN.
2013. Impact of Obesity on Cancer. Invited. Ho Chi Minh City, VN.
2013. Impact of Diabetes on HER2+ Breast Cancer. Invited. Hanoi, VN.
2013. Impact on antidiabetic medications on hyperglycemic patients with acute lymphocytic leukemia. Invited. Hanoi, VN.
2013. Impact of Obesity on ER + Breast Cancer. Invited. Hanoi, VN.
2013. A physician-scientist at a Comprehensive Cancer Center: What am I doing?. Invited. Ho Chi Minh City, CN.
2013. The Impact of Diabetes and Anti-Diabetic Medications on Cancer. Invited. Houston, TX, US.
2013. Oncologic Emergencies: The perspective from a Comprehensive Cancer Care Center. Invited. Shanwei, CN.
2013. My Personal Journey to be a Physician-Scientist. An Institutional Seminar. Invited. Shantou, CN.
2013. The Impact of Diabetes and Antidiabetic Medications on Cancers. Invited. Guangzhou, US.
2012. Oncologic Emergencies: show and tell. Invited. Hangzhou, CN.
2012. So you want to be a physician-scientist?. Visiting. Guangzhou, CN.
2012. TP53 is a novel substrate of Aurora B kinase. Invited. Guangzhou, CN.
2012. Thyroid diseases: the internet as a study resource. Visiting. Guangzhou, CN.
2012. Oncologic Emergencies: show and tell. Invited. Dong Guan, CN.
2012. Oncologic Emergencies: show and tell. Invited. Guangzhou, CN.
2011. TP53 is a novel substrate of Aurora B kinase. Invited. Guangzhou, CN.
2011. Oncologic Emergencies: The perspective at a comprehensive cancer center. Invited. Guangzhou, CN.
2010. The impact of obesity and type II diabetes mellitus on cancer. Invited. Tianjin, CN.
2010. The impact of obesity and type II diabetes mellitus on cancer. Visiting. Shenyang, CN.
2010. The impact of obesity and type II diabetes mellitus on cancer. Invited. Xi’an, CN.
2010. Thyroid diseases: the internet as a study resource. Visiting. Xi’an, CN.
2010. The impact of obesity and type II diabetes mellitus on cancer. Invited. Guangzhou, CN.
2010. Oncologic Emergencies: The perspective at a comprehensive cancer center. Invited. Guangzhou, CN.
2009. The effect of aurora B kinase inhibitor on breast cancer. Invited. Guangzhou, CN.
2009. The effect of aurora B kinase inhibitor on breast cancer. Invited. San Juan, PR.
2008. The impact of type II diabetes mellitus and its treatments on cancer: cellular mechanisms. Invited. Beijing, CN.
2008. The impact of type II diabetes mellitus and its treatments on cancer: cellular mechanisms. Invited. Guangzhou, CN.
2008. Energy metabolism in cancer cells. Invited. Hong Kong, CN.
2006. Preclinical Studies of Chemotherapy for Anaplastic Thyroid Carcinoma Antineoplastic activity of combinations including combretastatin A4 phosphate in a mouse xenograft model. Invited. Taipei, CN.
2006. Oncologic Emergencies: The Perspective from the Emergency Center of a Comprehensive Cancer Center. Invited. Taipei, US.
2006. Oncologic Emergencies: The Perspective from the Emergency Center of a Comprehensive Cancer Center. Invited. Hua Lian, CN.
2006. Preclinical Studies of Chemotherapy for Anaplastic Thyroid Carcinoma. Invited. Guangzhou, CN.
2006. Oncologic emergencies: The Perspective from the Emergency Center of a Comprehensive Cancer. Invited. Guangzhou, CN.
2004. Yeung, S. C. Investigating chemotherapy for anaplastic thyroid cancer. Invited. Houston, TX, US.
2003. Yeung, S. C. Responding to Oncologic Emergencies. Invited. Houston, TX, US.
2000. Yeung, S. J. and Xu, G. The role of angiogenesis inhibition in the in vivo antineoplastic effect of manumycin plus paclitaxel. Invited. Guangzhou, Peoples' Republic, CN.

Less

Grant & Contract Support

Date:	2023 - 2024
Title:	Neuro network prediction of appropriate disposition from the Acute Cancer Care Center of cancer patients needing emergency treatment
Funding Source:	IRG
Role:	Co-I

Date:	2022 - 2026
Title:	Improving Emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)
Funding Source:	NIH/NCI
Role:	n/a
ID:	1-R01-CA267856

Date:	2018 - 2021
Title:	Xeno-miRs and host miRs in sepsis
Funding Source:	NIH/NIGMS
Role:	PI
ID:	1RO1GM122775-01A1

Date:	2016 - 2020
Title:	Effect of Soluble Corn Fiber supplementation for 1 year on bone metabolism in adolescents
Funding Source:	NIH/NIGMS
Role:	Collaborator
ID:	1SC1HD089556-01

Date:	2014 - 2016
Title:	A randomized trial to compare fentanyl nasal spray with intravenous opioids to treat severe pain in cancer patients in the emergency department setting
Funding Source:	DepoMed Pharmaceuticals
Role:	PI

Date:	2014 - 2016
Title:	A Randomized Controlled Double-blind Trial of the Added Value of Fentanyl Nasal Spray (Lazanda) to Hydromorphone Demand PCA for Treatment of Severe Cancer Pain in the Emergency Department
Funding Source:	DepoMed Pharmaceuticals
Role:	Co-PI

Date:	2013 - 2015
Title:	Molecular and Cellular Signaling Transduction Pathways
Funding Source:	Vietnam Education Foundation
Role:	Co-I

Date:	2013 - 2014
Title:	A double-blind placebo-based pilot trial of calcium alumina-silicate (CASAD) in the treatment in the treatment of severe diarrhea (grade 3 or 4) in cancer patients presenting for emergency care
Funding Source:	Salient Pharmaceuticals
Role:	PI
ID:	2013-0452

Date:	2012 - 2013
Title:	The Impact of Obesity and Diabetes on the Survival of Myeloma Patients
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Principal Investigator-MDACC
ID:	SPORE in Multiple Myeloma Career Development Program (CDP) (P50 CA142509)

Date:	2010 - 2011
Title:	The evaluation of Pim kinase inhibitors in pancreatic cancer
Funding Source:	AstraZeneca
Role:	PI

Date:	2008 - 2013
Title:	UPRCCC/MDACC Partnership for Excellence in Cancer Research, Pilot Case-Comparison Study of Metabolic Syndrome and Estrogen-Receptor-Positive Breast Cancer in Puerto Rico
Funding Source:	NIH/NCI
Role:	Co-Program Leader
ID:	5-U54-CA-096300-08

Date:	2008 - 2014
Title:	The impact of obesity and obesity treatment on breast cancer
Funding Source:	Susan G. Komen Breast Cancer Foundation
Role:	PI
ID:	KG081048

Date:	2008 - 2013
Title:	The impact of obesity and obesity treatment on breast cancer
Funding Source:	Susan G. Komen Breast Cancer Foundation
Role:	Principal Investigator-MDACC
ID:	KG081048

Date:	2007 - 2008
Title:	The Impact of Diabetes Mellitus on the Survival of Breast Cancer
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	PI

Date:	2007 - 2009
Title:	The Impact of Diabetes Mellitus on the Survival of Breast Cancer
Funding Source:	Department of Defense (DOD)
Role:	PI
ID:	DOD-SIDA-BC062166

Date:	2007 - 2008
Title:	The impact of diabetes mellitus on the survival of breast cancer
Funding Source:	Breast Cancer Spore
Role:	Principal Investigator-MDACC

Date:	2006
Title:	Phase II Study of Decitabine in Patients with Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Radioiodine
Funding Source:	NCI
Role:	Co-I

Date:	2006 - 2008
Title:	Diabetes Mellitus and Impaired Glucose Tolerance in Cancer Patients
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	PI

Date:	2005 - 2008
Title:	Hortobagyi
Funding Source:	NIH/NCI
Role:	PI

Date:	2005 - 2006
Title:	The combination of carboplatin, paclitaxel and combretastatin A-4 phosphate in the treatment of anaplastic thyroid cancer. Oxigene
Funding Source:	N/A
Role:	PI

Date:	2005 - 2006
Title:	A phase II study of Bevacizumab and PEG interferon alpha-2b (PEG-Intron) in patients with metastatic or unresectable carcinoid tumors
Funding Source:	NCI-SAIC
Role:	Collaborator
ID:	ID02-063

Title:	A Single-center, Randomized, Open-label, Prospective, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime-Avibactam (CAZ-AVI) Plus Vancomycin or Linezolid Versus Standard of Care Plus Vancomycin or Linezolid as Empiric Therapy in Febrile Neutropenic Adults with Cancer
Funding Source:	AstraZeneca
Role:	Collaborator
ID:	Protocol 2014-1048

Selected Publications

Peer-Reviewed Articles

Nath, S, Qdaisat, AZ, Derkach, A, Babar, A, Zalavadia, D, Chaftari, P, Li, Z, Wattana, M, Schmeltz, J, Johnston, RP, Ortiz, EJ, Alagappan, K, Klotz, A, Yeung, SJ. Development and Validation of a Prognostic Risk Score for Patients With Cancer and Neutropenic Fever Presenting to the Emergency Department. JACEP Open 7(2), 2026. e-Pub 2026.
Yang, W, Ma, SC, Fang, Z, Liu, Y, Zhang, X, Fang, W, Wang, C, Wang, Y, Wang, X, Chen, W, Luo, H, Yang, L, Zhang, S, Zeng, B, Liu, ZG, Ou, Q, Cai, J, Yeung, SJ, Cheng, C. TP53-centric ctDNA complements PET/CT for non-invasive assessment of pathological complete response and survival after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. International Journal of Surgery 111(5):3256-3268, 2025. e-Pub 2025. PMID: 40146232.
Wechsler AH, Sandoval M, Viets-Upchurch J, Cruz Carreras M, Page VD, Elsayem A, Qdaisat A, Yeung SJ. Prior Advanced Care Planning and Outcomes of Cardiopulmonary Resuscitation in the Emergency Department of a Comprehensive Cancer Center. Cancers (Basel) 16(16), 2024. e-Pub 2024. PMID: 39199606.
Wang L, Lin Y, Yao Z, Babu N, Lin W, Chen C, Du L, Cai S, Pan Y, Xiong X, Ye Q, Ren H, Zhang D, Chen Y, Yeung SJ, Bremer E, Zhang H. Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases. Drug Resist Updat 76:101118, 2024. e-Pub 2024. PMID: 39094301.
Yeung SJ, Qdaisat A, Bischof JJ, Caterino JM, Kyriacou DN, Coyne Md C. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. Am J Emerg Med 80:227.e1-227.e5, 2024. e-Pub 2024. PMID: 38705758.
He X, Ji J, Qdaisat A, Esteva FJ, Yeung SJ. Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study. Lancet Reg Health Am 32:100712, 2024. e-Pub 2024. PMID: 38495316.
Reyes-Gibby CC, Qdaisat A, Ferrarotto R, Fadol A, Bischof JJ, Coyne CJ, Lipe DN, Hanna EY, Shete S, Abe JI, Yeung SJ. Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors. Head Neck 46(3):627-635, 2024. e-Pub 2024. PMID: 38151809.
Reyes-Gibby CC, Caterino JM, Coyne CJ, Kyriacou DN, Qdaisat A, McQuade J, Owen DH, Bischof JJ, Shete S, Yeung SJ. Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi). Emerg Cancer Care 3(1), 2024. e-Pub 2024. PMID: 38725994.
Li, K, Lin, Y, Zhou, Y, Xiong, X, Wang, L, Li, J, Zhou, F, Guo, Y, Chen, S, Chen, Y, Tang, H, Qiu, X, Cai, S, Zhang, D, Bremer, E, Yeung, SJ, Zhang, H. Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer. Gastroenterology 165(4):932-945.e9, 2023. e-Pub 2023. PMID: 37399999.
Ji Y, Liang Y, Chu PH, Ge M, Yeung SC, Ip MSM, Mak JCW. The effects of intermittent hypoxia on hepatic expression of fatty acid translocase CD36 in lean and diet-induced obese mice. Biomed J 46(5):100566, 2023. e-Pub 2023. PMID: 36244649.
Liu S, Guo R, Xu H, Yang J, Luo H, Yeung SJ, Li K, Lee MH, Yang R. 14-3-3sigma-NEDD4L axis promotes ubiquitination and degradation of HIF-1alpha in colorectal cancer. Cell Rep 42(8):112870, 2023. e-Pub 2023. PMID: 37494179.
Dong H, Lin W, Du L, Yao Z, Li F, Chen S, Huang Y, Ren H, Luo Y, Cai S, Chen Y, Tang H, Qiu X, Pan Y, Huang X, Zhang D, Gao S, Yeung SJ, Zhang H. PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET. Cancer Lett 567:216283, 2023. e-Pub 2023. PMID: 37331584.
Dragomir, M, Fuentes-Mattei, E, Winkle, M, Okubo, K, Bayraktar, R, Knutsen, E, Qdaisat, AZ, Chen, M, Li, Y, Shimizu, M, Pang, L, Liu, K, Liu, X, Anfossi, S, Zhang, H, Koch, I, Tran, AM, Mohapatra, S, Ton, AN, Kaplan, M, Anderson, MW, Rothfuss, SJ, Silasi, R, Keshari, RS, Ferracin, M, Ivan, C, Rodriguez-Aguayo, C, Lopez Berestein, G, Georgescu, C, Banerjee, PP, Basar, R, Li, Z, Horst, D, Vasilescu, C, Bertilaccio, MS, Rezvani, K, Lupu, F, Yeung, SJ, Calin, GA. Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. Journal of Clinical Investigation 133(14), 2023. e-Pub 2023. PMID: 37261908.
Yao, Z, Dong, H, Zhu, J, Du, L, Luo, Y, Liu, Q, Liu, S, Lin, Y, Wang, L, Wang, S, Wei, W, Zhang, K, Huang, Q, Yu, X, Zhao, W, Xu, H, Qiu, X, Pan, Y, Huang, X, Yeung, SJ, Zhang, D, Zhang, H. Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment. JCI Insight 8(14), 2023. e-Pub 2023. PMID: 37485875.
Abe JI, Imanishi M, Li S, Zhang A, Ko KA, Samanthapudi VSK, Lee LL, Bojorges AP, Gi YJ, Hobbs BP, Deswal A, Herrmann J, Lin SH, Chini EN, Shen YH, Schadler KL, Nguyen TH, Gupte AA, Reyes-Gibby C, Yeung SJ, Abe RJ, Olmsted-Davis EA, Krishnan S, Dantzer R, Palaskas NL, Cooke JP, Pownall HJ, Yoshimoto M, Fujiwara K, Hamilton DJ, Burks JK, Wang G, Le NT, Kotla S. An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis. Circ Res 133(1):25-44, 2023. e-Pub 2023. PMID: 37264926.
Lipe DN, Qdaisat A, Chaftari P, Wattana MK, Krishnamani PP, Reyes-Gibby C, Yeung SJ. Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy. Front Oncol 13:1122329, 2023. e-Pub 2023. PMID: 37007139.
Krishnamani PP, Qdaisat A, Wattana MK, Lipe DN, Sandoval M, Elsayem A, Cruz Carreras MT, Yeung SJ, Chaftari PS. Characteristics and Outcomes of Patients with Cancer Pain Placed in an Emergency Department Observation Unit. Cancers (Basel) 14(23), 2022. e-Pub 2022. PMID: 36497353.
Wang X, Yang W, Zhou Q, Luo H, Chen W, Yeung SJ, Zhang S, Gan Y, Zeng B, Liu Z, Feng S, Zhang X, Cheng C. The role of (18)F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 49(12):4241-4251, 2022. e-Pub 2022. PMID: 35732974.
Qdaisat A, Wechsler AH, Cruz Carreras MT, Menendez JR, Lipe D, Highsmith EA, Kamal M, Al-Breiki A, Rojas Hernandez CM, Wu CC, Yeung SJ. Concomitant Deep Vein Thrombosis in Cancer Patients with Unsuspected Pulmonary Embolism. Cancers (Basel) 14(18), 2022. e-Pub 2022. PMID: 36139673.
Bischof JJ, Elsaid MI, Bridges JFP, Rosko AE, Presley CJ, Abar B, Adler D, Bastani A, Baugh CW, Bernstein SL, Coyne CJ, Durham DD, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR, Venkat A, Wilson J, Yeung SJ, Yilmaz S, Caterino JM. Characterization of older adults with cancer seeking acute emergency department care: A prospective observational study. J Geriatr Oncol 13(7):943-951, 2022. e-Pub 2022. PMID: 35718667.
QdaisatORCID A, WechslerORCID AH, Cruz Carreras MT, Menendez JR, Lipe D, Highsmith EA, KamalORCID M, Al-Breiki A, Rojas HernandezORCID CM, J Yeung CCWA. Concomitant Deep Vein Thrombosis in Cancer Patients with Unsuspected Pulmonary Embolism. cancers, 2022. e-Pub 2022.
Lipe DN, Qdaisat A, Rajha E, Al-Breiki A, Cruz Carreras MT, Chaftari P, Yeung SJ, Rice TW. Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis. Res Pract Thromb Haemost 6(6):e12761, 2022. e-Pub 2022. PMID: 36000091.
Xiong X, Ke X, Wang L, Lin Y, Wang S, Yao Z, Li K, Luo Y, Liu F, Pan Y, Yeung SJ, Helfrich W, Zhang H. Neoantigen-based cancer vaccination using chimeric RNA-loaded dendritic cell-derived extracellular vesicles. J Extracell Vesicles 11(8):e12243, 2022. e-Pub 2022. PMID: 35927827.
Demis N Lipe MD, Aiham Qdaisat MD, Eva Rajha MD, Aisha Al-Breiki MD, Cruz Carrera MT, Patrick Chaftari MD, Sai-ching J Yeung MD, Terry W Rice MD. Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis, 2022. e-Pub 2022.
Yilmaz S, Grudzen CR, Durham DD, McNaughton C, Marcelin I, Abar B, Adler D, Bastani A, Baugh CW, Bernstein SL, Bischof JJ, Coyne CJ, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Pallin DJ, Reyes-Gibby C, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR, Venkat A, Wilson J, Yeung SJ, Caterino JM. Palliative Care Needs and Clinical Outcomes of Patients with Advanced Cancer in the Emergency Department. J Palliat Med 25(7):1115-1121, 2022. e-Pub 2022. PMID: 35559758.
Babakhanlou R, Yeung S. Assessment of minor head injuries in cancer patients on antiangiogenic treatment. American Journal of Emergency Medicine, 2022. e-Pub 2022.
Klotz, A, Caterino, JM, Durham, DD, Rico, JF, Pallin, DJ, Grudzen, CR, McNaughton, C, Marcelin, I, Abar, B, Adler, D, Bastani, A, Bernstein, SL, Bischof, JJ, Coyne, CJ, Henning, DJ, Hudson, MF, Lyman, GH, Madsen, TE, Reyes-Gibby, CC, Ryan, RJ, Shapiro, NI, Swor, R, Thomas, CR, Venkat, A, Wilson, J, Yeung, SJ, Yilmaz, S, Stutman, R, Baugh, CW. Observation unit use among patients with cancer following emergency department visits. Academic Emergency Medicine 29(2):174-183, 2022. e-Pub 2022. PMID: 34811858.
Liu Z, Yin J, Zhou Q, Yang J, Zeng B, Yeung SJ, Shen J, Cheng C. Survival after pulmonary metastasectomy for relapsed osteosarcoma. J Thorac Cardiovasc Surg 163(2):469-479.e8, 2022. e-Pub 2022. PMID: 33349447.
Qdaisat A, Yeung SJ, Rojas Hernandez CH, Samudrala P, Kamal M, Li Z, Wechsler AH. Characteristics and Outcomes of Intracranial Hemorrhage in Cancer Patients Visiting the Emergency Department. J Clin Med 11(3), 2022. e-Pub 2022. PMID: 35160096.
Li K, Lin Y, Luo Y, Xiong X, Wang L, Durante K, Li J, Zhou F, Guo Y, Chen S, Chen Y, Zhang D, Yeung SJ, Zhang H. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Mol Cancer 21(1):21, 2022. e-Pub 2022. PMID: 35042519.
He X, Dai X, Ji J, Liu H, Shi G, Yeung SJ. Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients. Clin Breast Cancer 22(1):e80-e90, 2022. e-Pub 2022. PMID: 34312098.
Reyes-Gibby C, Qdaisat A, Lipe D, Abe J, Yeung S. A preliminary assessment of cardiotoxicities associated with immune-checkpoint inhibitor therapy, 2022. e-Pub 2022.
Yang W, Xing X, Yeung SJ, Wang S, Chen W, Bao Y, Wang F, Feng S, Peng F, Wang X, Chen S, He M, Zhang N, Wang H, Zeng B, Liu Z, Kidane B, Seder CW, Koyanagi K, Shargall Y, Luo H, Peng S, Cheng C. Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma. J Immunother Cancer 10(1), 2022. e-Pub 2022. PMID: 35022193.
Imanishi M, Cheng H, Kotla S, Deswal A, Le NT, Chini E, Ko KA, Samanthapudi VSK, Lee LL, Herrmann J, Xu X, Reyes-Gibby C, Yeung SJ, Schadler KL, Yusuf SW, Liao Z, Nurieva R, Amir ED, Burks JK, Palaskas NL, Cooke JP, Lin SH, Kobayashi M, Yoshimoto M, Abe JI. Radiation therapy induces immunosenescence mediated by p90RSK. Front Cardiovasc Med 9:988713, 2022. e-Pub 2022. PMID: 36426217.
Qdaisat A, Bedrose S, Ezzeldin O, Moawad AW, Yeung SJ, Elsayes KM, Habra MA. The prevalence and spectrum of reported incidental adrenal abnormalities in abdominal computed tomography of cancer patients: The experience of a comprehensive cancer center. Front Endocrinol (Lausanne) 13:1023220, 2022. e-Pub 2022. PMID: 36457558.
Banerjee P, Olmsted-Davis EA, Deswal A, Nguyen MT, Koutroumpakis E, Palaskas NL, Lin SH, Kotla S, Reyes-Gibby C, Yeung SJ, Yusuf SW, Yoshimoto M, Kobayashi M, Yu B, Schadler K, Herrmann J, Cooke JP, Jain A, Chini E, Le NT, Abe JI. Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. J Cardiovasc Aging 2, 2022. e-Pub 2022. PMID: 35801078.
Ren JL, Rojo RD, Perez JVD, Yeung SJ, Hanna EY, Reyes-Gibby CC. Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors. BMC Cancer 21(1):1304, 2021. e-Pub 2021. PMID: 34872526.
Chaftari P, Chaftari AM, Hachem R, Yeung SJ, Dagher H, Jiang Y, Malek AE, Dailey Garnes N, Mulanovich VE, Raad I. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med 10(23):8475-8482, 2021. e-Pub 2021. PMID: 34725958.
He X, Ji J, Dai X, Qdaisat AZ, Esteva FJ, Hortobagyi GN, Yeung SJ. Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors. Clin Cancer Res 27(19):5343-5352, 2021. e-Pub 2021. PMID: 34117035.
Hudson M, Strassels S, Durham D, Siddique S, Adler D, Yeung S, Bernstein S, Baugh C, Coyne C, Grudzen C, Henning D, Klotz A, Madsen T, Pallin D, Rico J, Ryan R, Shapiro N, Swor R, Venkat A, Wilson J, Thomas C, Bischof J, Lyman G, Caterino J. Examining pain among non- Hispanic Black and non- Hispanic White patients with cancer visiting emergency departments: CONCERN (Comprehensive Oncologic Emergencies Research Network). Academic Emergency Medicine, 2021. e-Pub 2021.
Araji G, Maamari J, Ahmad F, Zareef R, Chaftari P, Yeung S. The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review. Innovations Journal, 2021. e-Pub 2021.
Chaftari P, Qdaisat A, Chaftari AM, Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G, Yeung SJ. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439240.
Coyne CJ, Reyes-Gibby CC, Durham DD, Abar B, Adler D, Bastani A, Bernstein SL, Baugh CW, Bischof JJ, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Pallin DJ, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR Jr, Venkat A, Wilson J, Yeung SJ, Caterino JM. Cancer pain management in the emergency department: a multicenter prospective observational trial of the Comprehensive Oncologic Emergencies Research Network (CONCERN). Support Care Cancer 29(8):4543-4553, 2021. e-Pub 2021. PMID: 33483789.
He X, Ji J, Dai X, Qdaisat A, Esteva F, Hortobagyi G, Yeung S. Association of cardiovascular disease risk factors with late cardiotoxicity and survival in HER2-positive breast cancer survivors. Clinical Cancer Research, 2021. e-Pub 2021.
Wu J, Yeung SJ, Liu S, Qdaisat A, Jiang D, Liu W, Cheng Z, Liu W, Wang H, Li L, Zhou Z, Liu R, Yang C, Chen C, Yang R. Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS. Signal Transduct Target Ther 6(1):188, 2021. e-Pub 2021. PMID: 34045438.
Chou PC, Choi HH, Huang Y, Fuentes-Mattei E, Velazquez-Torres G, Zhang F, Phan L, Lee J, Shi Y, Bankson JA, Wu Y, Wang H, Zhao R, Yeung SJ, Lee MH. Impact of diabetes on promoting the growth of breast cancer. Cancer Commun (Lond) 41(5):414-431, 2021. e-Pub 2021. PMID: 33609419.
XuexinHe, XiaolanDai, JialiJi, HongLiu, GanggangShi, JimYeung S. Nine-year median follow up of cardiotoxicity and efficacy of trastuzumab concurrently with anthracycline-based and anthracycline-free neoadjuvant chemotherapy in HER2-positive breast cancer patients. Elsevier, 2021. e-Pub 2021.
Wang, L, Xiong, X, Yao, Z, Zhu, J, Lin, Y, Lin, W, Li, K, Xu, X, Guo, Y, Chen, Y, Pan, Y, Zhou, F, Fan, J, Chen, Y, Gao, SG, Yeung, SJ, Zhang, H. Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer. Cancer Letters 501:1-11, 2021. e-Pub 2021. PMID: 33388371.
Wang L, Du L, Xiong X, Lin Y, Zhu J, Yao Z, Wang S, Guo Y, Chen Y, Geary K, Pan Y, Zhou F, Gao S, Zhang D, Yeung SJ, Zhang H. Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling. Oncogene 40(11):1974-1987, 2021. e-Pub 2021. PMID: 33603170.
Liu W, Qdaisat A, Ferrarotto R, Fuller CD, Guo M, Meyer LA, Narayanan S, Lopez G, Cohen L, Bruera E, Hanna EY, Yeung SJ. Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. Cancer 127(4):528-534, 2021. e-Pub 2021. PMID: 33085092.
Liu W, Qdaisat A, Zhou S, Fuller CD, Ferrarotto R, Guo M, Lai SY, Cardoso R, Mohamed ASR, Lopez G, Narayanan S, van Dijk LV, Cohen L, Bruera E, Yeung SJ, Hanna EY. Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers. Head Neck 43(2):613-621, 2021. e-Pub 2021. PMID: 33094893.
Coyne CJ, Reyes-Gibby CC, Durham DD, Abar B, Adler D, Bastani A, Bernstein SL, Baugh CW, Bischof JJ, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Pallin DJ, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas Jr CR, Venkat A, Wilson J, Yeung SJ, Caterino JM. Cancer pain management in the emergency department: a multicenter prospective observational trial of the Comprehensive Oncologic Emergencies Research Network (CONCERN). Journal of Clinical Review & Case Reports, 2021. e-Pub 2021. PMID: 333483789.
Yang W, Chen CH, Jia M, Xing X, Gao L, Tsai HT, Zhang Z, Liu Z, Zeng B, Yeung SJ, Lee MH, Cheng C. Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 9:641270, 2021. e-Pub 2021. PMID: 33681225.
Reyes-Gibby CC, Wang J, Zhang L, Peterson CB, Do KA, Jenq RR, Shelburne S, Shah DP, Chambers MS, Hanna EY, Yeung SJ, Shete S. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer 126(23):5124-5136, 2020. e-Pub 2020. PMID: 32888342.
Liu W, Qdaisat A, Lopez G, Narayanan S, Underwood S, Spano M, Reddy A, Guo Y, Yeung S, Bruera E, Cohen L. Association Between Acupoint Selection, Target Symptoms, and Traditional Chinese Medicine Diagnosis in Real-Time Clinical Practice in a Comprehensive Cancer Center. Intgrative Cancer Therapies, 2020. e-Pub 2020. PMID: 32508209.
Yeung SJ, Qdaisat A, Chaftari P, Lipe D, Merlin J, Rajha E, Wechsler A, Sandoval M, Viets J, Al-Breiki A, Shah M, Pandey R, Kamal M, Khattab O, Toale K, Wattana M, Elsayem A, Gaeta S, Brock P, Reyes-Gibby C, Alagappan K. Diagnosis and management of immune-related adverse effects of immune checkpoint therapy in the emergency department. J Am Coll Emerg Physicians Open 1(6):1637-1659, 2020. e-Pub 2020. PMID: 33392573.
Sai‐Ching Jim Yeung MD, PhD, Aiham Qdaisat MD, Patrick Chaftari MD, Demis Lipe MD, Jeffrey Merlin MD, Eva Rajha MD, Adriana Wechsler MD, Marcelo Sandoval MD, Jayne Viets MD, Aisha Al‐Breiki MD, Mohsin Shah MD, Ramesh Pandey MD, Mona Kamal MD, PhD, Osama Khattab MD, PharmD KT, Monica Wattana MD, Ahmed Elsayem MD, Susan Gaeta MD, Patricia Brock MD, DrPH CR, Kumar Alagappan MD. Diagnosis and management of immune‐related adverse effects of immune checkpoint therapy in the emergency department. Journal of the American College of Emergency Physicians Open, 2020. e-Pub 2020.
Yeung SJ, Elsayem A. Early Palliative Care for Patients With Advanced Lung Cancer: Opportunities in the ED. CHEST, 2020. e-Pub 2020. PMID: 33280746.
Yang R, He M, Wang D, Ye R, Li L, Deng R, Shah M, Yeung SJ. Association of cancer screening and residing in a coal-polluted East Asian region with overall survival of lung cancer patients: a retrospective cohort study. Sci Rep 10(1):17432, 2020. e-Pub 2020. PMID: 33060705.
Choi HH, Zou S, Wu JL, Wang H, Phan L, Li K, Zhang P, Chen D, Liu Q, Qin B, Nguyen TAT, Yeung SJ, Fang L, Lee MH. EGF Relays Signals to COP1 and Facilitates FOXO4 Degradation to Promote Tumorigenesis. Adv Sci (Weinh) 7(20):2000681, 2020. e-Pub 2020. PMID: 33101846.
Chaftari P, MD, Chaftari A, MD, Hachem RY, MD, Yeung S, MD, dagher H, MD, Jiang Y, MS, Malek A, MD, Mulonovich V, MD, Raad II, MD, Raad II, MD. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center. Open Forum Infectious Diseases, 2020. e-Pub 2020.
Wang S, Lin Y, Xiong X, Wang L, Guo Y, Chen Y, Chen S, Wang G, Lin P, Chen H, Yeung SJ, Bremer E, Zhang H. Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clin Cancer Res 26(18):4921-4932, 2020. e-Pub 2020. PMID: 32646922.
Wen KC, Sung PL, Wu ATH, Chou PC, Lin JH, Huang CF, Yeung SJ, Lee MH. Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer. J Ovarian Res 13(1):95, 2020. e-Pub 2020. PMID: 32825834.
Velazquez-Torres G, Fuentes-Mattei E, Choi HH, Yeung SJ, Meng X, Lee MH. Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth. Gastroenterol Rep (Oxf) 8(4):261-276, 2020. e-Pub 2020. PMID: 32843973.
Yang W, You N, Jia M, Yeung SJ, Ou W, Yu M, Wang Y, Fu X, Zhang Z, Yang J, Lao Z, Liu Z, Zeng B, Ou Q, Wu X, Shao YW, Hong X, Wang S, Cheng C. Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients. Lung Cancer 146:327-334, 2020. e-Pub 2020. PMID: 32623075.
Yeung S, Qdaisat A, Chaftari P, Lipe D, Merlin J, Rajha E, Wechsler A, Sandoval M, Viets J, Al-Breiki A, Shah M, Pandey R, Kamal M, Khattab O, Toale K, Wattana M, Elsayem A, Gaeta S, Brock P, Reyes-Gibby C, Alagappan K. Diagnosis and Management of Immune-Related Adverse Effects. The Practice of Emergency Medicine:1-23, 2020. e-Pub 2020.
Qdaisat A, Kamal M, Al-Breiki A, Goswami B, Wu CC, Zhou S, Rice TW, Alagappan K, Yeung SJ. Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients. Blood Adv 4(8):1606-1614, 2020. e-Pub 2020. PMID: 32311012.
Sandoval M, Banala S, Cruz Carreras M, Lipe D, Yeung S, Hanna E, TOdd K, Alagappan K, Reyes Gibby C. Hypertension and Emergency Department Visits by Patients with Head and Neck Cancer. Journal of Cardiology & Cardiovascular Therapy 16(1). e-Pub 2020.
Abu-Sbeih H, Faleck DM, Ricciuti B, Mendelsohn RB, Naqash AR, Cohen JV, Sellers MC, Balaji A, Ben-Betzalel G, Hajir I, Zhang J, Awad MM, Leonardi GC, Johnson DB, Pinato DJ, Owen DH, Weiss SA, Lamberti G, Lythgoe MP, Manuzzi L, Arnold C, Qiao W, Naidoo J, Markel G, Powell N, Yeung SJ, Sharon E, Dougan M, Wang Y. Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease. J Clin Oncol 38(6):576-583, 2020. e-Pub 2020. PMID: 31800340.
Qdaisat A, Yeung SJ, Variyam DE, Badugu P, Ghaly F, Rice TW, Halm JK, Carter BW, Sun J, Gonzalez CE, Viets-Upchurch J, Steele JR, Wu CC. Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians Guideline. J Am Coll Radiol 17(1 Pt A):22-30, 2020. e-Pub 2020. PMID: 31376398.
Banala SR, Khattab OK, Page VD, Warneke CL, Todd KH, Yeung SJ. Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: A randomized controlled trial. PLoS One 15(7):e0235461, 2020. e-Pub 2020. PMID: 32649717.
He X, Ji J, Tian M, Esteva FJ, Hortobagyi GN, Yeung SJ. Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer. Clin Cancer Res 25(24):7388-7395, 2019. e-Pub 2019. PMID: 31515457.
Liu W, Qdaisat A, Lee E, Yeung J, Vu K, Lin JZ, Canada T, Zhou S, Cohen L, Bruera E, Yeung SJ. The association between weight stability and parenteral nutrition characteristics and survival in patients with colorectal cancer. Gastroenterol Rep (Oxf) 7(6):419-425, 2019. e-Pub 2019. PMID: 31857903.
Shah M, Jomaa MK, Ferrarotto R, Yeung SJ, Hanna EY, Reyes-Gibby CC. Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review. Head Neck 41(11):4036-4050, 2019. e-Pub 2019. PMID: 31414560.
Jizzini MN, Shah M, Yeung SJ. Extramedullary Plasmacytoma Involving the Trachea: A Case Report and Literature Review. J Emerg Med 57(3):e65-e67, 2019. e-Pub 2019. PMID: 31266689.
Liu Z, Liu Y, Xie C, Yang J, Zeng B, Yeung SJ, Cheng C. Vagus nerve and phrenic nerve guided systematic nodal dissection for lung cancer. J Thorac Dis 11(9):4021-4027, 2019. e-Pub 2019. PMID: 31656677.
Adler D, Abar B, Durham DD, Bastani A, Bernstein SL, Baugh CW, Bischof JJ, Coyne CJ, Grudzen CR, Henning DJ, Hudson MF, Klotz A, Lyman GH, Madsen TE, Pallin DJ, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Thomas CR Jr, Venkat A, Wilson J, Yeung SJ, Caterino JM. Validation of the Emergency Severity Index (Version 4) for the Triage of Adult Emergency Department Patients With Active Cancer. J Emerg Med 57(3):354-361, 2019. e-Pub 2019. PMID: 31353265.
Qdaisat A, Wu CC, Yeung SJ. Normal D-dimer levels in cancer patients with radiologic evidence of pulmonary embolism. J Thromb Thrombolysis 48(1):174-179, 2019. e-Pub 2019. PMID: 31041652.
El Majzoub I, Qdaisat A, Chaftari PS, Yeung SJ, Sawaya RD, Jizzini M, Carreras MTC, Abunafeesa H, Elsayem AF. Association of emergency department admission and early inpatient palliative care consultation with hospital mortality in a comprehensive cancer center. Support Care Cancer 27(7):2649-2655, 2019. e-Pub 2019. PMID: 30474736.
Liu W, Qdaisat A, Soliman PT, Ramondetta L, Lopez G, Narayanan S, Zhou S, Cohen L, Bruera E, Yeung SJ. Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin. Oncologist 24(6):e312-e317, 2019. e-Pub 2019. PMID: 30940743.
Lin Y, Dong H, Deng W, Lin W, Li K, Xiong X, Guo Y, Zhou F, Ma C, Chen Y, Ren H, Yang H, Dai N, Ma L, Meltzer SJ, Yeung SJ, Zhang H. Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma. Clin Cancer Res 25(10):3035-3045, 2019. e-Pub 2019. PMID: 30745298.
Yam C, Esteva FJ, Patel MM, Raghavendra AS, Ueno NT, Moulder SL, Hess KR, Shroff GS, Hodge S, Koenig KH, Chavez Mac Gregor M, Griner RL, Yeung SJ, Hortobagyi GN, Valero V. Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study. Invest New Drugs 37(2):345-351, 2019. e-Pub 2019. PMID: 30610588.
Liu W, Qdaisat A, Yeung J, Lopez G, Weinberg J, Zhou S, Cohen L, Bruera E, Yeung SJ. The Association Between Common Clinical Characteristics and Postoperative Morbidity and Overall Survival in Patients with Glioblastoma. Oncologist 24(4):529-536, 2019. e-Pub 2019. PMID: 30049883.
Caterino JM, Adler D, Durham DD, Yeung SJ, Hudson MF, Bastani A, Bernstein SL, Baugh CW, Coyne CJ, Grudzen CR, Henning DJ, Klotz A, Madsen TE, Pallin DJ, Reyes-Gibby CC, Rico JF, Ryan RJ, Shapiro NI, Swor R, Venkat A, Wilson J, Thomas CR Jr, Bischof JJ, Lyman GH. Analysis of Diagnoses, Symptoms, Medications, and Admissions Among Patients With Cancer Presenting to Emergency Departments. JAMA Netw Open 2(3):e190979, 2019. e-Pub 2019. PMID: 30901049.
Maamari J, Yeung SJ, Chaftari PS. Diabetic ketoacidosis induced by a single dose of pembrolizumab. Am J Emerg Med 37(2):376.e1-376.e2, 2019. e-Pub 2019. PMID: 30361152.
El Majzoub I, Qdaisat A, Thein KZ, Win MA, Han MM, Jacobson K, Chaftari PS, Prejean M, Reyes-Gibby C, Yeung SJ. Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center. Ann Emerg Med 73(1):79-87, 2019. e-Pub 2019. PMID: 29880440.
Liu W, Qdaisat A, Lopez G, Narayanan S, Underwood S, Spano M, Reddy A, Guo Y, Zhou S, Yeung SC, Bruera E, Garcia MK, Cohen L. Acupuncture for Hot Flashes in Cancer Patients: Clinical Characteristics and Traditional Chinese Medicine Diagnosis as Predictors of Treatment Response. Integr Cancer Ther 18:1534735419848494, 2019. e-Pub 2019. PMID: 31046489.
He X, Ji J, Dong R, Liu H, Dai X, Wang C, Esteva FJ, Yeung SJ. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis. Breast Cancer Res Treat 173(2):329-341, 2019. e-Pub 2019. PMID: 30341462.
Yu J, Lin Y, Xiong X, Li K, Yao Z, Dong H, Jiang Z, Yu D, Yeung SJ, Zhang H. Detection of Exosomal PD-L1 RNA in Saliva of Patients With Periodontitis. Front Genet 10:202, 2019. e-Pub 2019. PMID: 30923536.
Ji J, Dai X, Yeung SJ, He X. The role of long non-coding RNA GAS5 in cancers. Cancer Manag Res 11:2729-2737, 2019. e-Pub 2019. PMID: 31114330.
El-Majzoub I, Qdaisat A, Chaftari PS, S-C Y, Sawaya RD, Jizzini M, Cruz Carreras MT, Abunafeesa H, Elsayem AF. Association of emergency department admission and early inpatient palliative care consultation with hospital mortality in a comprehensive cancer center. Supportive Care in Cancer, 2018. e-Pub 2018.
Han Q, Yeung SC, Ip MSM, Mak JCW. Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model. Lipids Health Dis 17(1):255, 2018. e-Pub 2018. PMID: 30428911.
Wang L, Li W, Li K, Guo Y, Liu D, Yao Z, Lin X, Li S, Jiang Z, Liu Q, Jiang Y, Zhang B, Chen L, Zhou F, Ren H, Lin D, Zhang D, Yeung SJ, Zhang H. The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma. Cancer Med 7(10):5205-5216, 2018. e-Pub 2018. PMID: 30270520.
Reyes-Gibby CC, Wang J, Yeung SJ, Chaftari P, Yu RK, Hanna EY, Shete S. Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep 8(1):8789, 2018. e-Pub 2018. PMID: 29884837.
Liu W, Qdaisat A, Yeung J, Lopez G, Weinberg JS, Zhou S, Cohen L, Bruera E, S-CJ Y. The association between common clinical characteristics and postoperative morbidity and overall survival in patients with glioblastoma. The Oncologist, 2018. e-Pub 2018.
Thein KZ, Yeung SJ, Oo TH. Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta-analysis of randomized controlled trials (RCTs). Asia Pac J Clin Oncol 14(3):210-16, 2018. e-Pub 2018. PMID: 28949077.
Yang Z, Yang R, Kwak MJ, Qdaisat A, Lin J, Begley CE, Reyes-Gibby CC, Yeung SJ. Oncologic emergencies in a cancer center emergency department and in general emergency departments countywide and nationwide. PLoS One 13(2):e0191658, 2018. e-Pub 2018. PMID: 29462166.
Kelly RS, Lasky-Su J, Yeung SJ, Stone RM, Caterino JM, Hagan SC, Lyman GH, Baden LR, Glotzbecker BE, Coyne CJ, Baugh CW, Pallin DJ. Integrative omics to detect bacteremia in patients with febrile neutropenia. PLoS One 13(5):e0197049, 2018. e-Pub 2018. PMID: 29768470.
Ahn S, Rice TW, Yeung SJ, Cooksley T. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents. Support Care Cancer 26(5):1465-70, 2018. e-Pub 2018. PMID: 29168032.
Banala SR, Yeung SJ, Rice TW, Reyes-Gibby CC, Wu CC, Todd KH, Peacock WF, Alagappan K. Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study. Int J Emerg Med 10(1):19, 2017. e-Pub 2017. PMID: 28589462.
Elsayem AF, Bruera E, Valentine A, Warneke CL, Wood GL, Yeung SJ, Page VD, Silvestre J, Brock PA, Todd KH. Advance Directives, Hospitalization, and Survival Among Advanced Cancer Patients with Delirium Presenting to the Emergency Department: A Prospective Study. Oncologist 22(11):1368-1373, 2017. e-Pub 2017. PMID: 28765503.
Win MA, Thein KZ, Qdaisat A, Yeung SJ. Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism. Am J Emerg Med 35(7):1039.e5-1039.e7, 2017. e-Pub 2017. PMID: 28363614.
Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GA. Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine 20:182-192, 2017. e-Pub 2017. PMID: 28465156.
Reyes-Gibby CC, Melkonian SC, Hanna EY, Yeung SJ, Lu C, Chambers MS, Banala SR, Gunn GB, Shete SS. Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck 39(6):1195-1204, 2017. e-Pub 2017. PMID: 28346771.
Acharya GK, Hita AG, Yeung SJ, Yeung SJ. Diabetic Ketoacidosis and Acute Pancreatitis: Serious Adverse Effects of Everolimus. Ann Emerg Med 69(5):666-667, 2017. e-Pub 2017. PMID: 28442095.
Win MA, Thein KZ, Yeung SJ. Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an ED. Am J Emerg Med 35(4):663.e1-663.e2, 2017. e-Pub 2017. PMID: 27836313.
Dong H, Xu J, Li W, Gan J, Lin W, Ke J, Jiang J, Du L, Chen Y, Zhong X, Zhang D, Yeung SJ, Li X, Zhang H. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis. J Pathol 241(4):448-462, 2017. e-Pub 2017. PMID: 27801498.
Arun B, Austin T, Babiera GV, Basen-Engquist K, Carmack CL, Chaoul A, Cohen L, Connelly L, Haddad R, Harrison C, Li Y, Mallaiah S, Nagarathna R, Parker PA, Perkins GH, Reuben JM, Shih YT, Spelman A, Sood A, Yang P, Yeung SJ. A Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience. Integr Cancer Ther 16(1):3-20, 2017. e-Pub 2017. PMID: 27903842.
Win MA, Thein KZ, Yeung SJ. Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an ED. Am J Emerg Med 35(4):663 e1-e2, 2017. e-Pub 2017. PMID: 27836313.
Vasilescu C, Dragomir M, Tanase M, Giza D, Purnichescu-Purtan R, Chen M, Yeung SJ, Calin GA. Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis. PLoS One 12(8):e0183334, 2017. e-Pub 2017. PMID: 28820886.
Yang F, Lei Q, Li L, He JC, Zeng J, Luo C, Yeung SJ, Yang R. Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity. PLoS One 12(11):e0188025, 2017. e-Pub 2017. PMID: 29131861.
Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM, Xie Q, Markan KR, Li W, Potthoff MJ, Fuentes-Mattei E, Ellies LG, Knudson CM, Lee MH, Yeung SJ, Cassel SL, Sutterwala FS, Zhang W. Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun 7:13007, 2016. e-Pub 2016. PMID: 27708283.
Elsayem AF, Bruera E, Valentine AD, Warneke CL, Yeung SC, Page VD, Wood GL, Silvestre J, Holmes HM, Brock PA, Todd KH. Delirium frequency among advanced cancer patients presenting to an emergency department: A prospective, randomized, observational study. Cancer 122(18):2918-24, 2016. e-Pub 2016. PMID: 27455035.
Miller AH, Brock P, Jim Yeung SC. Pituitary Dysfunction: A Case Series of Immune Checkpoint Inhibitor-Related Hypophysitis in an Emergency Department. Ann Emerg Med 68(2):249-50, 2016. e-Pub 2016. PMID: 27451306.
Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z, Du L, Zheng L, Ke C, Huang X, Song H, Kumar R, Yeung SC, Zhang H. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Oncogene, 2016. e-Pub 2016. PMID: 27345410.
Tu SM, Bilen MA, Hess KR, Broaddus RR, Kopetz S, Wei C, Pagliaro LC, Karam JA, Ward JF, Wood CG, Rao P, Tu ZH, General R, Chen AH, Nieto YL, Yeung SC, Lin SH, Logothetis CJ, Pisters LL. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer 122(12):1836-43, 2016. e-Pub 2016. PMID: 27018785.
Elsayem AF, Merriman KW, Gonzalez CE, Yeung SC, Chaftari PS, Reyes-Gibby C, Todd KH. Presenting Symptoms in the Emergency Department as Predictors of Intensive Care Unit Admissions and Hospital Mortality in a Comprehensive Cancer Center. J Oncol Pract 12(5):e554-63, 2016. e-Pub 2016. PMID: 27072570.
Miller AH, Yeung SC. Hypercortisolism Manifesting as Severe Weight Loss, Hypokalemia, and Hyperglycemia in the Emergency Department. J Emerg Med 50(4):e187-90, 2016. e-Pub 2016. PMID: 26896288.
Reyes-Gibby CC, Wang J, Silvas MR, Yu R, Yeung SC, Shete S. MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients. BMC Genet 17:40, 2016. e-Pub 2016. PMID: 26872611.
Yang Z, Qdaisat A, Hu Z, Wagar EA, Reyes-Gibby C, Meng QH, Yeung SC. Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study. PLoS One 11(4):e0153492, 2016. e-Pub 2016. PMID: 27077648.
Bankson JA, Walker CM, Ramirez MS, Stefan W, Fuentes D, Merritt ME, Lee J, Sandulache VC, Chen Y, Phan L, Chou PC, Rao A, Yeung SC, Lee MH, Schellingerhout D, Conrad CA, Malloy C, Sherry AD, Lai SY, Hazle JD. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res 75(22):4708-17, 2015. e-Pub 2015. PMID: 26420214.
Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, Lee MH, Yeung SC, Habra MA. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res 75(19):4131-42, 2015. e-Pub 2015. PMID: 26282167.
Zhou DS, Wang HB, Zhou ZG, Zhang YJ, Zhong Q, Xu L, Huang YH, Yeung SC, Chen MS, Zeng MS. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma. Oncotarget, 2015. e-Pub 2015. PMID: 26219398.
Gao S, Fang L, Phan LM, Qdaisat A, Yeung SC, Lee MH. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer. Oncotarget 6(29):28026-41, 2015. e-Pub 2015. PMID: 26318036.
Fang L, Lu W, Choi HH, Yeung SC, Tung JY, Hsiao CD, Fuentes-Mattei E, Menter D, Chen C, Wang L, Wang J, Lee MH. ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development. Cancer Cell 28(2):183-97, 2015. e-Pub 2015. PMID: 26267535.
Choi HH, Phan L, Chou PC, Su CH, Yeung SC, Chen JS, Lee MH. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth. Oncotarget 6(23):19721-34, 2015. e-Pub 2015. PMID: 26254224.
Dasari A, Phan A, Gupta S, Rashid A, Yeung SC, Hess K, Chen H, Tarco E, Chen H, Wei C, Anh-Do K, Halperin D, Meric-Bernstam F, Yao J. Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors. Endocr Relat Cancer 22(3):431-41, 2015. e-Pub 2015. PMID: 25900182.
Choi HH, Su CH, Fang L, Zhang J, Yeung SC, Lee MH. CSN6 deregulation impairs genome integrity in a COP1-dependent pathway. Oncotarget 6(14):11779-93, 2015. e-Pub 2015. PMID: 25957415.
Li Z, Zou X, Xie L, Chen H, Chen Y, Yeung SC, Zhang H. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma. Int J Cancer 136(7):1636-45, 2015. e-Pub 2015. PMID: 25159681.
Reyes-Gibby CC, Yuan C, Wang J, Yeung SC, Shete S. Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction. BMC Syst Biol 9:25, 2015. e-Pub 2015. PMID: 26044620.
Wu W, Liu X, Chaftari P, Cruz Carreras MT, Gonzalez C, Viets-Upchurch J, Merriman K, Tu SM, Dalal S, Yeung SC. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review. PLoS One 10(3):e0122047, 2015. e-Pub 2015. PMID: 25822612.
Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM. Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Rep Oncol Med 2015:471861, 2015. e-Pub 2015. PMID: 25861496.
Reyes-Gibby CC, Wang J, Yeung SJ, Shete S. Informative gene network for chemotherapy-induced peripheral neuropathy. BioData Min 8:24, 2015. e-Pub 2015. PMID: 26269716.
Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Rizk N, Wen YY, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Habra M, Yang W, Pusztai L, Yeung SC, Lee MH. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming. Nat Commun 6:7530, 2015. e-Pub 2015. PMID: 26179207.
Li D, Mao Y, Chang P, Liu C, Hassan MM, Yeung SJ, Abbruzzese JL. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer. Am J Cancer Res 5(10):3260-9, 2015. e-Pub 2015. PMID: 26693076.
Bazerbashi H, Merriman KW, Toale KM, Chaftari P, Cruz Carreras MT, Henderson JD, Yeung SC, Rice TW. Low tissue oxygen saturation at emergency center triage is predictive of intensive care unit admission. J Crit Care 29(5):775-9, 2014. e-Pub 2014. PMID: 24973103.
Pérez CM, Ortiz AP, Fuentes-Mattei E, Velázquez-Torres G, Santiago D, Giovannetti K, Bernabe R, Lee MH, Yeung SC. High Prevalence of Cardiometabolic Risk Factors in Hispanic Adolescents: Correlations with Adipocytokines and Markers of Inflammation. J Immigr Minor Health 16(5):865-73, 2014. e-Pub 2014. PMID: 23828626.
Li X, Zhang Y, Yeung SC, Liang Y, Liang X, Ding Y, Ip MS, Tse HF, Mak JC, Lian Q. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage. Am J Respir Cell Mol Biol 51(3):455-65, 2014. e-Pub 2014. PMID: 24738760.
O'Connor G, McGinty T, Yeung SJ, O'Shea D, Macken A, Brazil E, Mallon P. Cross-sectional study of the characteristics, healthcare usage, morbidity and mortality of injecting drug users attending an inner city emergency department. Emerg Med J 31(8):625-9, 2014. e-Pub 2014. PMID: 23625509.
Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, Wang M, Qazilbash MH, Baladandayuthapani V, Berry D, Orlowski RZ, Lee MH, Yeung SC. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. Br J Cancer 111(3):628-36, 2014. e-Pub 2014. PMID: 24921909.
Fuentes-Mattei E, Velazquez-Torres G, Phan L, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Zhao R, Chen J, Gully C, Carlock C, Qi Y, Zhang Y, Wu Y, Esteva FJ, Luo Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Fraser Symmans W, Lee MH, Yeung SC. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer. J Natl Cancer Inst 106(7), 2014. e-Pub 2014. PMID: 24957076.
Lai YR, Hong JM, Liu ZG, Deng ZS, Yeung SC, Cheng C. Bilateral pulmonary artery aneurysms, coronary artery aneurysm, and ventricular pseudoaneurysm in Behcet disease. Ann Vasc Surg 28(3):741.e7-10, 2014. e-Pub 2014. PMID: 24495331.
Phan LM, Yeung SC, Lee MH. Cancer Metabolic Reprogramming: Importance, Main Features, and Potentials for Precise Targeted Anti-Cancer Therapies. Cancer Biol Med 11(1):1-19, 2014. e-Pub 2014. PMID: 24738035.
Feng Y, Ke C, Tang Q, Dong H, Zheng X, Lin W, Ke J, Huang J, Yeung SC, Zhang H. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death Dis 5:e1088, 2014. e-Pub 2014. PMID: 24577086.
Wu W, Merriman K, Nabaah A, Seval N, Afshar-Kharghan V, Yeung SC. Heparin-induced thrombocytopenia among patients of a comprehensive cancer center. SAGE Open Med Case Rep 2:2050313X14533945, 2014. e-Pub 2014. PMID: 27489647.
Lai YR, Hong JM, Liu ZG, Deng ZS, Yeung SCJ, Cheng C. Bilateral Pulmonary Artery Aneurysms, Coronary Artery Aneurysm and Ventricular Pseudoaneurysm in Behcet’s Disease. Ann Vasc Surgery 28:741.e7-741.e10, 2014. e-Pub 2014.
Tudor S, Giza DE, Lin HY, Fabris L, Yoshiaki K, D'Abundo L, Toale KM, Shimizu M, Ferracin M, Challagundla KB, Cortez MA, Fuentes-Mattei E, Tulbure D, Gonzalez C, Henderson J, Row M, Rice TW, Ivan C, Negrini M, Fabbri M, Morris JS, Yeung SC, Vasilescu C, Calin GA. Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis 5:e1559, 2014. e-Pub 2014. PMID: 25476907.
Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, Yeung G, Qiao Y, Chou PC, Su CH, Hsieh YC, Hsu SL, Ohshiro K, Shaikenov T, Wang H, Yeung SC, Lee MH. CSN6 drives carcinogenesis by positively regulating Myc stability. Nat Commun 5:5384, 2014. e-Pub 2014. PMID: 25395170.
Ost DE, Yeung SC, Tanoue LT, Gould MK. Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd Edition: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e121S-41S, 2013. e-Pub 2013. PMID: 23649435.
Zhao R, Yang HY, Shin J, Phan L, Fang L, Che TF, Su CH, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle 12(6):935-43, 2013. e-Pub 2013. PMID: 23421998.
Hanzelka KM, Yeung SC, Chisholm G, Merriman KW, Gaeta S, Malik I, Rice TW. Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center. Support Care Cancer 21(3):727-34, 2013. e-Pub 2013. PMID: 22956191.
Cheng C, Liu Z, Xu F, Deng Z, Feng H, Lei Y, Zou J, Yeung SC. Clinical outcome of juvenile myasthenia gravis after extended transsternal thymectomy in a chinese cohort. Ann Thorac Surg 95(3):1035-41, 2013. e-Pub 2013. PMID: 23374447.
Esteva FJ, Moulder SL, Gonzalez-Angulo AM, Ensor J, Murray JL, Green MC, Koenig KB, Lee MH, Hortobagyi GN, Yeung SC. Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer. Cancer Chemother Pharmacol 71(1):63-2, 2013. e-Pub 2013. PMID: 23053261.
Yeung SC, Elsayem A, Fuller GN, Lu G, You MJ. Fatal acute monocytic leukemia with t(6;11)(q27;q23) translocation and KRAS mutation. J Clin Pathol 66(1):73-5, 2013. e-Pub 2013. PMID: 22923764.
Luo Y, Yang C, Ye M, Jin C, Abbruzzese JL, Lee MH, Yeung SC, McKeehan WL. Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations. Cancer Metab 1(1):21, 2013. e-Pub 2013. PMID: 24279986.
Wen YY, Chou PC, Phan L, Su CH, Chen J, Hsieh YC, Xue YW, Qu CJ, Gully C, Parreno K, Teng C, Hsu SL, Yeung SC, Wang HM, Lee MH. DNA damage-mediated c-Myc degradation requires 14-3-3 sigma. Cancer Hallmarks 1:3-17, 2013. e-Pub 2013.
Yang C, Lu W, Lin T, You P, Ye M, Huang Y, Jiang X, Wang C, Wang F, Lee MH, Yeung SC, Johnson RL, Wei C, Tsai RY, Frazier ML, McKeehan WL, Luo Y. Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress. BMC Gastroenterol 13:67, 2013. e-Pub 2013. PMID: 23590285.
Luo CQ, Yeung SC, Liu ZG, Meng J, Zhong FT, Cheng C. Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression. Cancer Biol Ther 13(14):1384-89, 2012. e-Pub 2012. PMID: 22986233.
Chen B, Zhao R, Su CH, Linan M, Tseng C, Phan L, Fang L, Yang HY, Yang H, Wang W, Xu X, Jiang N, Cai S, Jin F, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle 11(24):4633-41, 2012. e-Pub 2012. PMID: 23187808.
Xue Y, Chen J, Choi HH, Phan L, Chou PC, Zhao R, Yang H, Santiago J, Liu M, Yeung GE, Yeung SC, Lee MH. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle 11(22):4181-90, 2012. e-Pub 2012. PMID: 23095642.
Teng CL, Hsieh YC, Phan L, Shin J, Gully C, Velazquez-Torres G, Skerl S, Yeung SC, Hsu SL, Lee MH. FBXW7 is involved in Aurora B degradation. Cell Cycle 11(21):4059-68, 2012. e-Pub 2012. PMID: 23095493.
Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante C, Andreeff M, Kantarjian H, Lavis V, Yeung SC. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 12(5):355-62, 2012. e-Pub 2012. PMID: 22658895.
Tu SM, Som A, Tu B, Logothetis CJ, Lee MH, Yeung SC. Effect of Paget's disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis. Br J Cancer 107(4):646-51, 2012. e-Pub 2012. PMID: 22805323.
He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Ann Oncol 23(7):1771-80, 2012. e-Pub 2012. PMID: 22112968.
Pan J, Chen C, Jin Y, Fuentes-Mattei E, Velazquez-Tores G, Benito JM, Konopleva M, Andreeff M, Lee MH, Yeung SC. Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. Cell Cycle 11(12):2314-26, 2012. e-Pub 2012. PMID: 22659796.
Gully CP, Velazquez-Torres G, Shin JH, Fuentes-Mattei E, Wang E, Carlock C, Chen J, Rothenberg D, Adams HP, Choi HH, Guma S, Phan L, Chou PC, Su CH, Zhang F, Chen JS, Yang TY, Yeung SC, Lee MH. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci U S A 109(24):E1513-22, 2012. e-Pub 2012. PMID: 22611192.
Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 18(10):2905-12, 2012. e-Pub 2012. PMID: 22465831.
Wu Y, Chen C, Sun X, Shi X, Jin B, Ding K, Yeung SC, Pan J. Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor α and bcr-abl oncogene addiction in malignant hematologic cells. Clin Cancer Res 18(7):1966-78, 2012. e-Pub 2012. PMID: 22447844.
Matthias N, Lockworth CR, Zhang F, Lee MH, Yeung SC, Tsai KY, Hamir AN. Multiple cystic sweat gland tumors in transgenic mice. Comp Med 62(1):27-30, 2012. e-Pub 2012. PMID: 22330648.
He XX, Tu SM, Lee MH, Yeung SJ. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol 22(12):2640-2645, 2011. e-Pub 2011. PMID: 21415239.
Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, Zhao R, Phan L, Shaiken T, Chen J, Yeung SC, Lee MH. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene 30(48):4791-801, 2011. e-Pub 2011. PMID: 21625211.
Liu Z, Feng H, Yeung SC, Zheng Z, Liu W, Ma J, Zhong FT, Luo H, Cheng C. Extended transsternal thymectomy for the treatment of ocular myasthenia gravis. Ann Thorac Surg 92(6):1993-9, 2011. e-Pub 2011. PMID: 22115207.
Feng YH, Velazquez-Torres G, Gully C, Chen J, Lee MH, Yeung SC. The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med 15(4):825-36, 2011. e-Pub 2011. PMID: 20455996.
Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, Sahin A, Wang H, Wang H, Lai CC, Tsai FJ, Lozano G, Lee MH. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest 121(3):851-65, 2011. e-Pub 2011. PMID: 21317535.
Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res 71(3):884-94, 2011. e-Pub 2011. PMID: 21135113.
Zhao R, Fuentes-Mattei E, Velazquez-Torres G, Su CH, Chen J, Lee MH, Yeung SC. Exenatide improves glucocorticoid-induced glucose intolerance in mice. Diabetes Metab Syndr Obes 4:61-5, 2011. e-Pub 2011. PMID: 21448323.
Feng YH, Wang YW, Yeung SCJ. Current concepts of pain management for cancer patients. Oncology Review 2(3):154-63, 2011. e-Pub 2011.
Hanzelka KM, Zalpour A, Afshar-Kharghan V, Fitousis K, Anderlini P, Yeung SC. Severe thrombosis and acute thrombocytopenia in a cancer patient. Am J Hematol 85(11):887-90, 2010. e-Pub 2010. PMID: 20721891.
Su CH, Zhao R, Velazquez-Torres G, Chen J, Gully C, Yeung SC, Lee MH. Nuclear export regulation of COP1 by 14-3-3s in response to DNA damage. Mol Cancer 9:243, 2010. e-Pub 2010. PMID: 20843328.
Chen B, C-G L, Jin F, Y-N S, T-T Z, L-N Z, Li S, Yeung SC. The role of fine-wire localization breast biopsy in the management of BI-RADS category 3-5 non-palpable breast lesions in northeastern Chinese women. Health 2(4):291-294, 2010. e-Pub 2010.
Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, Gomez-Cabello D, Hawke DH, Yeung SC, Lee MH, Hortobagyi GN, Hung MC, Esteva FJ. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res 12(6):R96, 2010. e-Pub 2010. PMID: 21080941.
Becker TK, S-CJ Y. Drug-induced QT interval prolongation in cancer patients. Oncology Review 4(4):223-32, 2010. e-Pub 2010.
Gully CP, Zhang F, Chen J, Yeung JA, Velazquez-Torres G, Wang E, Yeung SC, Lee MH. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Mol Cancer 9:42, 2010. e-Pub 2010. PMID: 20175926.
Cheng C, Wu G, Yeung SC, Li R, Bella AE, Pang J, Zhong FT, Luo H, Jin Y, Pan J. Serum protein profiles in myasthenia gravis. Ann Thorac Surg 88(4):1118-23, 2009. e-Pub 2009. PMID: 19766792.
Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic Therapies Affect Risk of Pancreatic Cancer. Gastroenterology 137(2):482-8, 2009. e-Pub 2009. PMID: 19375425.
Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Yeung SC, Lee MH. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene 28(28):2581-92, 2009. e-Pub 2009. PMID: 19483729.
Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation. Am J Pathol 175(1):400-11, 2009. e-Pub 2009. PMID: 19528349.
Gullly C, Chen J, Zhang FM, Yeung J, Yeung SCJ, Lee MH. Antineoplastoc effects of an Aurora-B kinase inhibitor in breast cancer 69, 2009. e-Pub 2009.
Pan J, Chen B, Su CH, Zhao R, Xu ZX, Sun L, Lee MH, Yeung SC. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biol Ther 7(10):1679-84, 2008. e-Pub 2008. PMID: 18769123.
Cheng C, Yeung SC, Zhong FT, Xiong Y, Luo HH, Ji S, Pan J. Aneurysmal bone cyst in the first rib. Ann Thorac Surg 85(6):2118-20, 2008. e-Pub 2008. PMID: 18498837.
Yao JC, Phan A, Hoff PM, Chen HX, Charnsangavej C, Yeung SC, Hess K, Ng C, Abbruzzese JL, Ajani JA. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol 26(8):1316-23, 2008. e-Pub 2008. PMID: 18323556.
Reviews O. Feng Y-H, Wang Y-W, Yeung S-CJ. Current concepts of pain management for cancer patients 2(3):154, 2008. e-Pub 2008.
Yeung SC, She M, Yang H, Pan J, Sun L, Chaplin D. Combination Chemotherapy including Combretastatin A4 Phosphate and Paclitaxel is Effective against Anaplastic Thyroid Cancer in a Nude Mouse Xenograft Model. J Clin Endocrinol Metab 92(92:2902-2909):2902-9, 2007. e-Pub 2007. PMID: 17550961.
Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, Xie K, Ellis L, Abbruzzese JL, Ajani JA. Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res 13(1):234-40, 2007. e-Pub 2007. PMID: 17200360.
Huyghe E, Nohra J, Caron P, Bennet A, Khedis M, Otal P, Soulie M, Yeung SC, Plante P. Lethal posttraumatic rupture of a pheochromocytoma: lesson from a postmortem diagnosis. Urol Int 79(1):83-5, 2007. e-Pub 2007. PMID: 17627175.
She M, Yeung SC. Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model. Cancer Lett 238(2):197-201, 2006. e-Pub 2006. PMID: 16154259.
She M, Yang H, Sun L, Yeung SC. Redox control of manumycin A-induced apoptosis in anaplastic thyroid cancer cells: involvement of the xenobiotic apoptotic pathway. Cancer Biol Ther 5(3):275-80, 2006. e-Pub 2006. PMID: 16410725.
Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung SC, Sukumar S, Sidransky D. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 116(6):920-4, 2005. e-Pub 2005. PMID: 15856456.
Escalante CP, Weiser MA, Lam T, Ho V, Yeung SC. Hypertension in cancer patients seeking acute care: an opportunity to intervene. Am J Med Sci 330(3):120-7, 2005. e-Pub 2005. PMID: 16174995.
Pan J, Huang H, Sun L, Fang B, Yeung SC. Bcl-2-associated X protein is the main mediator of manumycin a-induced apoptosis in anaplastic thyroid cancer cells. J Clin Endocrinol Metab 90(6):3583-91, 2005. e-Pub 2005. PMID: 15769983.
Pan J, She M, Xu ZX, Sun L, Yeung SC. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells. Cancer Res 65(9):3671-81, 2005. e-Pub 2005. PMID: 15867362.
She M, Pan I, Sun L, Yeung SC. Enhancement of manumycin A-induced apoptosis by methoxyamine in myeloid leukemia cells. Leukemia 19(4):595-602, 2005. e-Pub 2005. PMID: 15744347.
Pan JX, Huang HZ, Sun LL, Fang BL, Yeung SCJ. Bcl-2-associated X protein is the main mediator of manumycin A-induced apoptosis in anaplastic thyroid cancer cells. Journal of Clinical Endocrinology & Metabolism 90(6):3583-91, 2005. e-Pub 2005.
Dackiw A, Pan J, Xu G, Yeung SC. Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer. Surgery 138(3):456-463, 2005. e-Pub 2005. PMID: 16213899.
Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 10(24):8594-602, 2004. e-Pub 2004. PMID: 15623643.
Hu W, Wu W, Verschraegen CF, Chen L, Mao L, Yeung SC, Kudelka AP, Freedman RS, Kavanagh JJ. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics 3(10):1904-11, 2003. e-Pub 2003. PMID: 14625852.
Yang HL, Pan JX, Sun L, Yeung SC. p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells. J Clin Endocrinol Metab 88(2):763-72, 2003. e-Pub 2003. PMID: 12574211.
Ghori FY, Gutterman-Litofsky DR, Jamal A, Yeung SC, Arem R, Sherman SI. Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma. Thyroid 12(11):1009-16, 2002. e-Pub 2002. PMID: 12490079.
Hu W, Wu W, Yeung SC, Freedman RS, Kavanagh JJ, Verschraegen CF. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. Anticancer Res 22(2A):665-72, 2002. e-Pub 2002. PMID: 12014635.
Gonzales, J, Yeung, SJ, Smith, JA. A high performance liquid chromatography assay validation of manumycin A in mouse plasma. J Chromatography B 776:177-182, 2002. e-Pub 2002.
Pan J, Xu G, Yeung SC. Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel. J Clin Endocrinol Metab 86(10):4731-40, 2001. e-Pub 2001. PMID: 11600533.
Xu, GP, Pan, J, Martin, C, Yeung, SC. The role of angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. J. Clin. Endocrinol. Metab 86:1769-1777, 2001. e-Pub 2001. PMID: 11297616.
Yeung SC, Xu G, Pan J, Christgen M, Bamiagis A. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells. Cancer Res 60(3):650-6, 2000. e-Pub 2000. PMID: 10676649.
Yeung SJ, McCutcheon IE, Schultz P, Gagel RF. Use of long-term intravenous phosphate infusion in the palliative treatment of tumor-induced osteomalacia. J Clin Endocrinol Metab 85(2):549-55, 2000. e-Pub 2000. PMID: 10690854.
Liao W, Yeung SC, Chan L. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum. J Biol Chem 273(42):27225-30, 1998. e-Pub 1998. PMID: 9765244.
Yeung SC, Eton O, Burton DW, Deftos LJ, Vassilopoulou-Sellin R, Gagel RF. Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma. Horm Res 49(6):288-91, 1998. e-Pub 1998. PMID: 9623520.
Yeung SCJ, Chan L. Hepatic apoliprotein B biogenesis: An update. Trends in Cardiovascular Medicine 8(1):8-14, 1998. e-Pub 1998.
Yeung SC, Anderson J, Kobayashi K, Oka K, Chan L. Production of rabbit polyclonal antibody against apobec-1 by genetic immunization. J Lipid Res 38(12):2627-32, 1997. e-Pub 1997. PMID: 9458285.
Yeung SJ, Chen SH, Chan L. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B. Biochemistry 35(43):13843-8, 1996. e-Pub 1996. PMID: 8901527.
Yeung, SJ, Go, R, Balasubramanyam, A. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid 5(5):403-5, 1995. e-Pub 1995. PMID: 8563481.
Raju, U, Nunez-Regueiro, M, Cook, R, Kaetzel, MA, Yeung, SJ, Eskin, A. Identification of an annexin-like protein and its possible role in the Aplysia eye circadian system. J Neurochem 61(4):1236-45, 1993. e-Pub 1993. PMID: 8376982.
Bem WT, Yeung SJ, Belcheva M, Barg J, Coscia CJ. Age-dependent changes in the subcellular distribution of rat brain mu-opioid receptors and GTP binding regulatory proteins. J Neurochem 57(5):1470-7, 1991. e-Pub 1991. PMID: 1655974.
Raju U, Yeung SJ, Eskin A. Involvement of proteins in light resetting ocular circadian oscillators of Aplysia. Am J Physiol 258(1 Pt 2):R256-62, 1990. e-Pub 1990. PMID: 2154135.
Szucs M, Bem WT, S-CJ Y, Coscia CJ. Characterization of Intracellular Opioid Binding-Sites and G-Regulatory Proteins in Neonatal and Adult-Rat Brain,. European Journal of Pharmacology 186(6):2311, 1990. e-Pub 1990.
Yeung SJ, Eskin A. Responses of the circadian system in the Aplysia eye to inhibitors of protein synthesis. J. Biol. Rhythms 3:225-36, 1988. e-Pub 1988.
Yeung SJ, Eskin A. Involvement of a specific protein in the regulation of a circadian rhythm in Aplysia eye. Proc Natl Acad Sci U S A 84(1):279-83, 1987. e-Pub 1987. PMID: 3025861.
Eskin A, Yeung SJ, Klass MR. Requirement for protein synthesis in the regulation of a circadian rhythm by serotonin. Proc Natl Acad Sci U S A 81(23):7637-41, 1984. e-Pub 1984. PMID: 6095312.

Invited Articles

Yeung SCJ, Habra M. Thyroid: Anaplastic (undifferentiated) carcinoma. Atlas Genet Cytogenet Oncol Haematol(16):935(9), 2013. e-Pub 2013.
Yeung SCJ, Habra M. PTHLH (Parathyroid hormone-like hormone). Atlas Genet Cytogenet Oncol Haematol(17):94(1), 2013. e-Pub 2013.
Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle 10(18):3057-66, 2011. e-Pub 2011. PMID: 21876386.
Yeung SCJ. Thyroid: Anaplastic (undifferentiated) carcinoma. Atlas Genet Cytogenet Oncol Haematol 12(6):477(80), 2008. e-Pub 2008.
Yeung SCJ, Habra MA. PTHLH (parathyroid hormone-like hormone). Atlas Genet Cytogenet Oncol Haematol(12):234(9), 2008. e-Pub 2008.
Pan J, Yeung SC. Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors. Cancer Res 65(20):9109-12, 2005. e-Pub 2005. PMID: 16230362.
Chui AC, Yeung SC. Diagnostic Challenge: An endocrinologic enigma. Cortlandt Forum 13(3):55-57, 2000. e-Pub 2000.
Yeung SC, Chui AC. Difficult Diagnosis: A tale of two lesions – Cushing’s syndrome in a woman with lung and adrenal masses. Primary Care & Cancer 20:23-27, 2000. e-Pub 2000.
Yeung, SJ, Chui, AC, Balasubramanyam, A. Diagnostic Challenge: A young woman with no thirst for life. Cortlandt Forum 13(4):42-43, 2000. e-Pub 2000.
Chui AC, Yeung SJ. Clinical Update: Hypothyroidism. Cortlandt Forum 13(12):111-17, 2000. e-Pub 2000.
Yeung SC, Amato R, Gagel RF. Difficult Diagnosis: What is causing this patient's muscle weakness?. Primary Care & Cancer 19:5-9, 1999. e-Pub 1999.
Yeung SC, Chan L. Hepatic apolipoprotein B biogenesis: an update. Trends Cardiovasc Med 8(1):8-14, 1998. e-Pub 1998. PMID: 21235906.

Review Articles

Tran, D, Nguyen, H, Pham, VD, Nguyen, P, Nguyen Luu, H, Minh Phan, L, Blair DeStefano, C, Yeung, SJ, Nguyen, T. A comprehensive review of cancer survival prediction using multi-omics integration and clinical variables. Briefings in bioinformatics 26(2), 2025. e-Pub 2025. PMID: 40221959.
Zoghbi M, Moussa MJ, Dagher J, Haroun E, Qdaisat A, Singer ED, Karam YE, Yeung SJ, Chaftari P. Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management. Cancers (Basel) 16(14), 2024. e-Pub 2024. PMID: 39061222.
Kamal Jomaa, M, Chemaly, RF, Ibrahim, DA, Yeung, SJ, Rahouma, M. Impact of the oral microbial profile on the risk of treatment-related oral toxicities in patients with head and neck cancer before the 16S rRNA gene amplification sequencing technology era. Oral Oncology Reports 8, 2023. e-Pub 2023.
San Valentin EMD, Do KA, Yeung SJ, Reyes-Gibby CC. Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review. Int J Mol Sci 24(23), 2023. e-Pub 2023. PMID: 38069314.
Singer ED, Faiz SA, Qdaisat A, Abdeldaem K, Dagher J, Chaftari P, Yeung SJ. Hemoptysis in Cancer Patients. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835458.
He X, Yeung SJ, Esteva FJ. A new paradigm for classifying and treating HER2-positive breast cancer. Cancer Rep (Hoboken) 6(8):e1841, 2023. e-Pub 2023. PMID: 37254964.
Sandoval M, Wechsler AH, Alhajji Z, Viets-Upchurch J, Brock P, Lipe DN, Al-Breiki A, Yeung SJ. Evaluation and management of acute high-grade immunotherapy-related neurotoxicity. Heliyon 9(3):e13725, 2023. e-Pub 2023. PMID: 36851967.
Li X, Peng W, Wu J, Yeung SJ, Yang R. Advances in immune checkpoint inhibitors induced-cardiotoxicity. Front Immunol 14:1130438, 2023. e-Pub 2023. PMID: 36911712.
Jain A, Casanova D, Padilla AV, Paniagua Bojorges A, Kotla S, Ko KA, Samanthapudi VSK, Chau K, Nguyen MTH, Wen J, Hernandez Gonzalez SL, Rodgers SP, Olmsted-Davis EA, Hamilton DJ, Reyes-Gibby C, Yeung SJ, Cooke JP, Herrmann J, Chini EN, Xu X, Yusuf SW, Yoshimoto M, Lorenzi PL, Hobbs B, Krishnan S, Koutroumpakis E, Palaskas NL, Wang G, Deswal A, Lin SH, Abe JI, Le NT. Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. Front Cardiovasc Med 10:1212174, 2023. e-Pub 2023. PMID: 37781317.
Babakhanlou, R, Larkin, K, Hita, AG, Stroh, JJ, Yeung, SJ. Stoma-related complications and emergencies. International Journal of Emergency Medicine 15(1), 2022. e-Pub 2022. PMID: 35534817.
Gould Rothberg BE, Quest TE, Yeung SJ, Pelosof LC, Gerber DE, Seltzer JA, Bischof JJ, Thomas CR Jr, Akhter N, Mamtani M, Stutman RE, Baugh CW, Anantharaman V, Pettit NR, Klotz AD, Gibbs MA, Kyriacou DN. Oncologic emergencies and urgencies: A comprehensive review. CA Cancer J Clin 72(6):570-593, 2022. e-Pub 2022. PMID: 35653456.
Araji G, Maamari J, Ahmad FA, Zareef R, Chaftari P, Yeung SJ. The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review. J Immunother Precis Oncol 5(1):13-25, 2022. e-Pub 2022. PMID: 35663831.
Rajha E, Chaftari P, Kamal M, Maamari J, Chaftari C, Yeung SJ. Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy. Gastroenterol Rep (Oxf) 8(1):25-30, 2020. e-Pub 2020. PMID: 32104583.
Shah M, Rajha E, DiNardo C, Muckey E, Wierda WG, Yeung SJ. Adverse Events of Novel Therapies for Hematologic Malignancies: What Emergency Physicians Should Know. Ann Emerg Med 75(2):264-286, 2020. e-Pub 2020. PMID: 31561995.
Tai LW, Yeung SC, Cheung CW. Enriched Environment and Effects on Neuropathic Pain: Experimental Findings and Mechanisms. Pain Pract 18(8):1068-1082, 2018. e-Pub 2018. PMID: 29722923.
Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One 12(7):e0180396, 2017. e-Pub 2017. PMID: 28678827.
Giza DE, Fuentes-Mattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C, Calin GA. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ 23(12):1906-1918, 2016. e-Pub 2016. PMID: 27740627.
Yeung SC, Habra MA, Thosani SN. Lung cancer-induced paraneoplastic syndromes. Curr Opin Pulm Med 17(4):260-8, 2011. e-Pub 2011. PMID: 21577115.
Lee MH, Yeung SC. Intercepting Akt with DNAzyme: A nasopharyngeal carcinoma story. Cancer Biol Ther 8(4):372-4, 2009. e-Pub 2009. PMID: 19182540.
Yeung SJ, Pan J, Lee MH. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci 65(24):3981-99, 2008. e-Pub 2008. PMID: 18766298.
Feng YH, Wang YW, Yeung SC. Current concepts of pain management for cancer patients. Oncol Rev 2(3):204-213, 2008. e-Pub 2008.
Yeung SC, Gully C, Lee MH. Aurora-B kinase inhibitors for cancer chemotherapy. Mini Rev Med Chem 8(14):1514-25, 2008. e-Pub 2008. PMID: 19075809.
Yeung SC, Chiu AC, Vassilopoulou-Sellin R, Gagel RF. The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev 19(2):144-72, 1998. e-Pub 1998. PMID: 9570035.

Professional Educational Materials

Busaidy NL, Busaidy KF, Yeung SC. A 45-year-old man with a maxillary mass and hypercalcemia, 2005.
Jimenez C, Yeung SC. What is causing this patient bone pain and muscular weakness? A case report of Fanconi syndrome complicated with osteomalacia due to a lymphoma, 2003.

Editorials

Pan J, Song E, Cheng C, Lee MH, Yeung SC. Farnesyltransferase inhibitors-induced autophagy: alternative mechanisms?. Autophagy 5(1):129-31, 2009. PMID: 19066466.

Abstracts

Chaftari P, Chaftari A, Hachem R, Yeung S, Dagher H, Jiang Y, Malek A, Mulanovich V, Raad, I. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center, 2020. e-Pub 2020.
Qdaisat A, Wu C, Alsoud S, Yeung SJ. Performance of clinical decision rules in detective venous thromboembolism in cancer patients presented to the emergency department, 2018. e-Pub 2018.
Qdaisat A, AlSoud R, Wu C, Abdel-Razeq H, Yeung SJ. Diagnostic accuracy of D-dimer in cancer-associated venous thromboembolism, 2018. e-Pub 2018.
Yang R, Shi W, Yeung S. Improved prognosis of lung cancer patients in Xuanwei-Fuyuan counties, a high-incidence region of Yunnan Province in China, compared with the rest of Yunnan Province, 2018. e-Pub 2018.
Qdaisat A, Wu C, Yeung SJ. Clinical prediction rule for cancer-associated venous thromboembolism in patients presenting to the emergency department, 2018. e-Pub 2018.
Banala SR, Todd KH, Cruz Carreras MT, Yeung SC, Sandoval M, Reyes-Gibby CC. Hypertension is a predictor of Emergency Department visits among patients with head and neck cancer, 2017. e-Pub 2017.
Wechsler AH, Qdaisat A, Yeung SC. Incidence and mortality of spontaneous intracranial hemorrhage in oncologic patients presenting to the Emergency Department of a comprehensive cancer center, 2017. e-Pub 2017.
Banala SR, Yeung SC, Rice TW, Reyes-Gibby CC, Wu CC, Todd KH, Peacock WF, Alagappan K. Discharge or admit? Emergency Department management of incidental pulmonary embolism in patients with cancer, 2017. e-Pub 2017.
Elsayem AF, Bruera E, Valentine AD, Warneke CL, Wood GL, Yeung SC, Page VD, Silvestre J, Brock PA, Todd KH. Outcomes among patients with advanced cancer and delirium presenting to the Emergency Department, 2017. e-Pub 2017.
Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SC, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: an informative gene network analysis, 2017. e-Pub 2017.
Yang Z, Yang R, Kwak MJ, Qdaisat A, Lin J, Begley CE, Reyes-Gibby CC, Yeung SC. Oncologic emergencies in a cancer center Emergency Department and in general Emergency Departments countywide and nationwide, 2017. e-Pub 2017.
Bulbul A, Thein KZ, Araujo-Mino EP, S-CJ Y, Tsao-Wei D, Huber M, Chouial S, Awasthi S, Khorsand M. Prevalence and Prognostic Significance of CD5 Immunohistochemistry in De-Novo DLBCL in a Western Population Cohort, 2017. e-Pub 2017.
Bulbul A, Araujo-Mino EP, Huber M, Bautista A, Thein KZ, Husain H, Awasthi S, S-CJ Y, Khorsand M. Serious Cardiovascular Events and Clinical Outcomes in Secondary Polycythemia: Efficacy of Conventional Phlebotomy and Proposed Hematocrit Target, 2017. e-Pub 2017.
Win MA, Thein KZ, Qdaisat A, Han MM, Yeung SJ. Side efects of immune checkpoint therapy in cancer patients visiting the Emergency Department of a comprehensive cancer center, 2017. e-Pub 2017.
Lee MH, Fang L, Chen B, Choi HH, Shin JH, Phan L, S-C Y. COP9 signalosome in regulating EGFR oncogenic signals 4(S)::S5-S, 2017. e-Pub 2017.
Liu W, Qdaisat A, Yeung J, Lopez G, Weinberg JS, Choen L, Bruerar E, S-CJ Y. Association between clinical and biochemical indices and survival in glioblastoma patients, 2017. e-Pub 2017.
Thein KZ, Win MA, Yeung SC, Oo TH. Risk of Bleeding from Primary Thromboprophylaxis (PTP) in Patients with Solid Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT), 2016. e-Pub 2016.
Thein K, Yeung SC, Oo TH. A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT) in Ambulatory Thromboprophylaxis (ATP) in Patients with Lung Cancer Receiving Chemotherapy, 2016. e-Pub 2016.
Elsayem AF, Valentine AD, Warneke CL, Page VD, Bruera E, Yeung SC, Brock PA, Silvestre J, Holmes HM, Todd KH. Delirium Assessment in Advanced Cancer Patients Presenting to the Emergency Department of a Comprehensive Cancer Center, 2015. e-Pub 2015.
Habra M, Yeung SC, Lee MH. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma: A Potential Therapeutic Target, 2015. e-Pub 2015.
Elsayem A, Merriman K, Gonzalez C, Yeung SC, Chaftari P, Henderson J, Todd KH. Intensive Care Unit Admissions and Mortality in Patients admitted through the Emergency Department of a Comprehensive Cancer Center. Proceedings of ASCO 2014, 2014. e-Pub 2014.
Tu SM, Bilen MA, Tu ZH, General R, Ward JF, Pisters LL, General R, Chen AH, Nieto Y, Pagliaro LC, Yeung SJ, Logothetis C, Lin SH, Gorlov I. Nonseminomatous germ cell tumor of the testis: Prognostic factors for a lethal phenotype, 2014. e-Pub 2014.
Chou PC, Zhao R, Fuentes-Mattei E, Velazquez-Torre G, Zhang F, Qu C, Phan L, Lee J, Elliott A, Bankson JA, Wu Y, Wang H, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC. Anti-insulin resistance treatments suppress breast cancer growth and alter metabolic status, 2013. e-Pub 2013.
Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Gully C, Carlock C, Zhao R, Qi Y, Zhang Y, Wu Y, Esteva FJ, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes in Estrogen Receptor-Positive Breast Cancer, 2013. e-Pub 2013.
Shin J, Yang TY, Chou PC, Phan L, Chen J, Vázquez Vélez GE, Yeung SC, Lee MH. COP1 ubiquitin ligase Regulates FBW7 stability in a AKT dependent manner, 2013. e-Pub 2013.
Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, Lou Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes Enhancing the Cancer Hallmarks of ER-Positive Breast Cancer, 2013. e-Pub 2013.
Fuentes-Mattei E, Zhang F, Velazquez-Torres G, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Accelerates Oncogene-Driven Estrogen Receptor-Positive Breast Carcinogenesis, Coincident with Changes in Tumor Metabolism and Enhanced Epithelial-Mesenchymal Transition Gene Expression, 2013. e-Pub 2013.
Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, Lou Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes Enhancing the Cancer Hallmarks of ER-Positive Breast Cancer, 2013. e-Pub 2013.
Fuentes-Mattei E, Phan L, Velazquez-Torres G, Zhang F, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Colin C, Zhao R, Wu Y, Esteva FJ, Lou Y, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity Induces Functional Transcriptomic Changes Enhancing the Cancer Hallmarks of ER-Positive Breast Cancer, 2013. e-Pub 2013.
Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YW, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Lin X, Wang HA, Wang H, Zhang A, Xia X, Wu Y, Yang W, Pusztai L, Yeung SC, Lee MH. 14-3-3sigma regulates cancer metabolic reprogramming by targeting c-Myc. Proceedings of Cell Symposium Hallmarks of Cancer, 2012. e-Pub 2012.
Elsayem AF, Gonzalez CE, Yeung SC, Merriman K, Todd KH. In-hospital mortality of patients admitted through the emergency department of a comprehensive cancer center, 2012. e-Pub 2012.
Fuentes-Mattei E, Gully C, Velazquez-Torres G, Shin JH, Chen JS, Choi HH, Chou PC, Adams HP, Phan L, Yang TY, Yeung SC, Lee MH. Aurora B binds p53 during both interphase and mitosis, phosphorylates it and promotes its degradation, 2012. e-Pub 2012.
Fuentes-Mattei E, Gully C, Velazquez-Torres G, Shin JH, Chen JS, Choi HH, Chou PC, Adams HP, Phan L, Yang TY, Yeung SC, Lee MH. Aurora B binds p53 during both interphase and mitosis, phosphorylates it and promotes its degradation, 2012. e-Pub 2012.
Luo Y, Yang C, Lee MH, Yeung SC, McKeehan WL. Deficiency of Metabolic Regulator FGFR4 Elevates Endocrine FGF19 and FGF21 and Suppresses TGFa-driven Breast Cancer Progression, 2012. e-Pub 2012.
Phan L, Chou PC, Samudio I, Velazquez-Torres G, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng X, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Yang W, Pusztai L, Yeung SC, Lee MH. The tumor suppressor 14-3-3sigma is a new regulator of cancer metabolism, 2012. e-Pub 2012.
Fuentes-Mattei E, Zhang F, Velazquez-Torres G, Chou PC, Phan L, Shin JH, Choi HH, Chen JS, Gully C, Carlock C, Zhao R, Wu Y, Esteva FJ, McKeehan WL, Ensor J, Hortobagyi GN, Pusztai L, Symmans WF, Lee MH, Yeung SC. Obesity accelerates oncogene-driven estrogen receptor-positive breast carcinogenesis and cancer progression with enhanced glycolysis and epithelial–mesenchymal transition, 2012. e-Pub 2012.
Yeung SC, Zhao R, Chou B, Velazquez-Torres G, Fuentes-Mattei E, Lee MH. Diabetes mellitus accelerates ErbB2-induced breast carcinogenesis and shortens the survival of a mouse model of breast cancer and diabetes, 2011. e-Pub 2011.
Phan L, Samudio I, Chou PC, Parreno K, Velazquez-Torres G, Gully C, Huang Y, Tseng C, Vu T, Shao Y, Cody D, Delacerda J, Kingsley C, Zhang A, Xia X, Su CH, Choi HH, Wang E, Chen J, Carlock C, Zhou Z, Fuentes-Mattei E, Shin JH, Hsieh YC, Yeung SC, Lee MH. The tumor suppressor 14-3-3 sigma regulates glycolysis by targeting c-MYC, 2011. e-Pub 2011.
Fuentes-Mattei E, Velázquez-Torres G, Zhao R, Zhang F, Chou B, Gully C, Carlock C, Phan L, Wang H, Lee MH, Yeung SC. Development of MMTV-TGFα: Ay/a obese mouse model to study the effect of obesity on ER-positive breast cancer, 2011. e-Pub 2011.
Fuentes-Mattei E, Velázquez-Torres G, Zhao R, Zhang F, Chou B, Gully C, Carlock C, Phan L, Wang H, Lee MH, Yeung SC. The effect of obesity on ER-positive breast cancer, 2011. e-Pub 2011.
Fuentes-Mattei E, Velázquez-Torres G, Zhao R, Zhang F, Chou B, Gully C, Carlock C, Phan L, Wang H, Lee MH, Yeung SC. MMTV-TGFα: Ay/a obese mouse model to study the effect of obesity and anti-insulin resistance treatments on ER-positive breast cancer, 2011. e-Pub 2011.
Phan L, Velazquez‐Torres G, Samudio I, Gully C, Su CH, Wen Y, Yeung SC, Lee MH. 14-3-3 sigma suppresses cancer glycolysis, 2010. e-Pub 2010.
Gully C, Wang E, Velazquez-Torres G, Chen J, Carlock C, Yu W, Phan L, Zhang F, Yeung SC, Lee MH. Aurora B kinase has multi-layered control of tumor suppressor p53, 2010. e-Pub 2010.

Book Chapters

Yeung, SJ. Diarrhea, 357-365, 2021.
Yeung, SJ. Endocrinology and metabolism, 377-395, 2021.
Rajha, E, Yeung, SJ. Toxicities of novel antineoplastic therapies, 711-738, 2021.
Rajha E, Yeung S. Adverse effects of antineoplastic agents approved in the last decade. In: Oncologic Emergency Medicine: Principles and Practice. 2nd Edition. Springer International Publishing, 2021.
Yeung S, Chaftari P, Manzullo E. The MD Anderson Manual of Medical Oncology. In: Oncologic Emergencies. 4th, 2021.
Jr BR, Croce CM, Hait WN, Hong WK, Kufe DW, Piccart-Gebhart M, Pollack RE, Weichselbaum RR, Yang H, Holland, JF. Oncologic Emergencies. In: Holland-Frei Cancer Medicine. 9th Edition. Wiley-Blackwell, 2017.
Jr BR, Croce CM, Hait WN, Hong WK, Kufe DW, Piccart-Gebhart M, Pollack RE, Weichselbaum RR, Yang H, Holland, JF. Endocrine Complications and Paraneoplastic Syndromes. In: Holland-Frei Cancer Medicine. 9th Edition. Wiley-Blackwell, 2017.
Todd KH, Thomas CR. Endocrine and Metabolic Emergencies. In: Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016.
Todd KH, Thomas CR. Diarrhea in Cancer Patients. In: Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016.
Liu W, Yeung SC. Metabolic and Endocrine Oncologic Emergencies. In: Oncologic Emergencies. 1st Edition. Springer-Verlag New York, 2016.
Kantarjian H, Wolff R. Oncologic Emergencies. In: The MD Anderson Manual of Medical Oncology. 3rd Edition. McGraw Hill Medical, 2016.
Manzullo E, Yeung SJ, Gonzalez C, Escalante C. Metabolic and Endocrine Oncologic Emergencies. In: Oncologic Emergencies (M.D. Anderson Cancer Care Series). MD Anderson Cancer Center Press, 2016.
Yeung SJ, Escalante C. Cardiac emergencies in the cancer patient. In: Cancer and the Heart. 2nd Edition. PMPH-USA, 2012.
Pan J, Yeung SC. Farnesyltransferase inhibitors of microbial origins in cancer therapy. In: Emerging cancer therapy: microbial approaches and biotechnological tools. John Wiley & Sons Inc, 2010.
Yeung SJ, Gagel RF. Endocrine complications and paraneoplastic syndromes. In: Cancer Medicine. 8th Edition. BC Decker Inc, 2010.
Yeung SJ, Escalante C. Oncologic Emergencies. In: Cancer Medicine. 8th Edition. BC Decker Inc, 2010.
Yeung SJ, Gagel RF. Pituitary and adrenal complications in cancer patients. In: Medical Care of Cancer Patients. BC Decker Inc, 2009.
Lee MH, Yeung SJ, Yang HY. 14-3-3 family proteins and checkpoint response. In: Cancer Drug Discovery and Development: Checkpoint response in cancer therapy. Humana Press, 2009.
Lee MH, Yang H, Zhao R, Yeung SJ. Roles of negative and positive growth regulators in nasopharyngeal carcinoma. In: Apoptosis in Carcinogenesis and Chemotherapy. Springer Science + Business Media BV, 273-294, 2009.
Yeung SJ, Escalante C, Gagel RF. Survivorship - a reversal of fortune. In: Medical Care of Cancer Patients. BC Decker Inc, 2009.
Row M, Yeung SJ. Emergency care: special considerations in cancer patients. In: Medical Care of Cancer Patients. BC Decker Inc, 2009.
Hu MI, Yeung SJ, Gagel RF. Endocrine paraneoplastic syndromes. In: Medical Care of Cancer Patients. BC Decker Inc, 2009.
Yeung SJ, Gagel RF. Endocrine neoplastic syndromes. In: Medical Care of Cancer Patients. BC Decker Inc, 2009.
Yeung SJ. Cancer screening in cancer survivors. In: Medical Care of Cancer Patients. BC Decker Inc, 2009.
Yeung SJ, Escalante C. Cardiac emergencies in the cancer patient. In: Cancer and the Heart. PMPH-USA, 2006.
Habra MA, Busaidy NL, Yeung SJ, Vassilopoulou-Sellin R. Endocrine manifestations of non-endocrine tumors. In: The MD Anderson Manual of Medical Oncology. McGraw-Hill Professional, 2006.
Yeung SJ, Gagel RF. Endocrine complications and paraneoplastic syndromes. In: Cancer Medicine. 7th Edition. BC Decker Inc, 2005.
Yeung SJ. Preclinical Studies of Chemotherapy for Undifferentiated Thyroid Carcinoma, Chapter 7. In: Advances in Molecular and Cellular Endocrinology. Elsevier Science, 117-144, 2005.
Yeung SJ, Escalante C. Oncologic Emergencies. In: Cancer Medicine. 7th Edition. BC Decker Inc, 2005.
Yeung SJ, Gagel RF. Endocrine complications and paraneoplastic syndromes. In: Cancer Medicine. 6th Edition. BC Decker Inc, 2003.
Yeung SJ, Escalante C. Oncologic Emergencies. In: Cancer Medicine. 6th Edition. BC Decker Inc, 2003.
Yeung SJ, Lazo G, Gagel RF. Endocrine and Metabolic Emergencies. In: Oncologic Emergency. BC Decker Inc, 2002.
Yeung SJ. Orthopedic Oncologic Emergencies. In: Oncologic Emergency. BC Decker Inc, 2002.
Levett M, Row M, Yeung SJ. Miscellaneous Oncologic Emergencies. In: Oncologic Emergency. BC Decker Inc, 2002.
Yeung SJ, Gagel RF. Endocrine complications. In: Cancer Medicine. 5th Edition. BC Decker Inc, 2389-2398, 2000.
Yeung SJ, Hubbard JR. Endocrine and metabolic diseases. In: Primary Medicine for Psychiatrists: Practitioner’s Guide. Plenum Publishing Corp, 1-27, 1997.

Books (edited and written)

Todd KH, Thomas CR. Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016.
Manzullo E, Yeung SC, Gonzalez CE, Escalante C. Oncologic Emergency. MD Anderson Cancer Center Press, 2016.
Yeung SJ, Escalante C, Gagel RF. Medicine Care of Cancer Patients. B. C. Decker Inc, 2009.
Yeung SJ, Escalante C. Oncologic Emergency. B. C. Decker Inc, 2002.

Letters to the Editor

Babakhanlou, R, Yeung, SJ. Assessment of minor head injuries in cancer patients on antiangiogenic treatment. American Journal of Emergency Medicine 59: 204, 2022.
Hudson MF, Strassels SA, Durham DD, Siddique S, Adler D, Yeung SJ, Bernstein SL, Baugh CW, Coyne CJ, Grudzen CR, Henning DJ, Klotz A, Madsen TE, Pallin DJ, Rico JF, Ryan RJ, Shapiro NI, Swor R, Venkat A, Wilson J, Thomas CR, Bischof JJ, Lyman GH, Caterino JM. Examining pain among non-Hispanic Black and non-Hispanic White patients with cancer visiting emergency departments: CONCERN (Comprehensive Oncologic Emergencies Research Network). Acad Emerg Med 29: 364-368, 2022.
Guo Y, Li Y, Monroe-Wise A, Yeung SJ, Huang Y. A dynamic residential community-based quarantine strategy: China's experience in fighting COVID-19. Infect Control Hosp Epidemiol 41: 1363-1364, 2020.
Qdaisat A, Soud RA, Wu CC, Rojas Hernandez CM, Li J, Meng QH, Abdel-Razeq H, Yeung SJ. Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia. Haematologica 104: e265-e268, 2019.
Thein KZ, Yeung SJ, Oo TH. Reply to M. Alexander et al. Asia Pac J Clin Oncol 15: 185, 2019.

Less

CV information above last modified March 30, 2026

Sai-Ching J Yeung, B.S., R.Ph., M.S., Ph.D., M.D., F.A.C.P.

About Dr. Sai-Ching J Yeung

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Clinical Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Professional Educational Materials

Other Articles

Editorials

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson